The	O
Epstein-Barr	B-protein
virus	I-protein
oncoprotein	I-protein
latent	I-protein
membrane	I-protein
protein	I-protein
1	I-protein
engages	O
the	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor-associated	I-protein
proteins	I-protein
TRADD	B-protein
and	O
receptor-interacting	B-protein
protein	I-protein
(	O
RIP	B-protein
)	O
but	O
does	O
not	O
induce	O
apoptosis	O
or	O
require	O
RIP	B-protein
for	O
NF-kappaB	B-protein
activation	O
.	O

A	O
site	O
in	O
the	O
Epstein-Barr	B-protein
virus	I-protein
(	I-protein
EBV	I-protein
)	I-protein
transforming	I-protein
protein	I-protein
LMP1	B-protein
that	O
constitutively	O
associates	O
with	O
the	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor	I-protein
1	I-protein
(	I-protein
TNFR1	I-protein
)	I-protein
-associated	I-protein
death	I-protein
domain	I-protein
protein	I-protein
TRADD	B-protein
to	O
mediate	O
NF-kappaB	B-protein
and	O
c-Jun	B-protein
N-terminal	I-protein
kinase	I-protein
activation	O
is	O
critical	O
for	O
long-term	O
lymphoblastoid	O
cell	O
proliferation	O
.	O

We	O
now	O
find	O
that	O
LMP1	B-protein
signaling	O
through	O
TRADD	B-protein
differs	O
from	O
TNFR1	B-protein
signaling	O
through	O
TRADD	B-protein
.	O

LMP1	B-protein
needs	O
only	O
11	O
amino	O
acids	O
to	O
activate	O
NF-kappaB	B-protein
or	O
synergize	O
with	O
TRADD	B-protein
in	O
NF-kappaB	B-protein
activation	O
,	O
while	O
TNFR1	B-protein
requires	O
approximately	O
70	O
residues	O
.	O

Further	O
,	O
LMP1	B-protein
does	O
not	O
require	O
TRADD	B-protein
residues	O
294	O
to	O
312	O
for	O
NF-kappaB	B-protein
activation	O
,	O
while	O
TNFR1	B-protein
requires	O
TRADD	B-protein
residues	O
296	O
to	O
302	O
.	O

LMP1	B-protein
is	O
partially	O
blocked	O
for	O
NF-kappaB	B-protein
activation	O
by	O
a	O
TRADD	B-protein
mutant	O
consisting	O
of	O
residues	B-protein
122	I-protein
to	I-protein
293	I-protein
.	O

Unlike	O
TNFR1	B-protein
,	O
LMP1	B-protein
can	O
interact	O
directly	O
with	O
receptor-interacting	B-protein
protein	I-protein
(	O
RIP	B-protein
)	O
and	O
stably	O
associates	O
with	O
RIP	B-protein
in	O
EBV-transformed	B-cell_line
lymphoblastoid	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Surprisingly	O
,	O
LMP1	B-protein
does	O
not	O
require	O
RIP	B-protein
for	O
NF-kappaB	B-protein
activation	O
.	O

Despite	O
constitutive	O
association	O
with	O
TRADD	B-protein
or	O
RIP	B-protein
,	O
LMP1	B-protein
does	O
not	O
induce	O
apoptosis	O
in	O
EBV-negative	B-cell_line
Burkitt	I-cell_line
lymphoma	I-cell_line
or	I-cell_line
human	I-cell_line
embryonic	I-cell_line
kidney	I-cell_line
293	I-cell_line
cells	I-cell_line
.	O

These	O
results	O
add	O
a	O
different	O
perspective	O
to	O
the	O
molecular	O
interactions	O
through	O
which	O
LMP1	B-protein
,	O
TRADD	B-protein
,	O
and	O
RIP	B-protein
participate	O
in	O
B-lymphocyte	O
activation	O
and	O
growth	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BloLOGY	NULL
,	NULL
Aug.	NULL
1999	NULL
,	NULL
p.	NULL
5759-5767	NULL
0270-7306/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

8	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
Virus	NULL
Oncoprotein	NULL
Latent	NULL
Membrane	NULL
Protein	NULL
1	NULL
Engages	NULL
the	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
Receptor-Associated	NULL
Proteins	NULL
TRADD	NULL
and	NULL
Receptor-Interacting	NULL
Protein	NULL
(	NULL
RIP	NULL
)	NULL
but	NULL
Does	NULL
Not	NULL
Induce	NULL
Apoptosis	NULL
or	NULL
Require	NULL
RIP	NULL
for	NULL
NF-	NULL
«	NULL
kB	NULL
Activation	NULL
KENNETH	NULL
M.	NULL
IZUMI	NULL
,	NULL
'	NULL
ELLEN	NULL
CAHIR	NULL
McFARLAND	NULL
,	NULL
!	NULL

ADRIAN	NULL
T.	NULL
TING	NULL
,	NULL
``	NULL
ELISABETH	NULL
A.	NULL
RILEY	NULL
,	NULL
't	NULL
BRIAN	NULL
SEED	NULL
,	NULL
``	NULL
anp	NULL
ELLIOTT	NULL
D.	NULL
KIEFF'*	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
and	NULL
Channing	NULL
Laboratories	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115-5804	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Genetics	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02114	NULL
Received	NULL
1	NULL
December	NULL
1998/Returned	NULL
for	NULL
modification	NULL
11	NULL
February	NULL
1999/Accepted	NULL
29	NULL
April	NULL
1999	NULL
A	NULL
site	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
transforming	NULL
protein	NULL
LMP1	NULL
that	NULL
constitutively	NULL
associates	NULL
with	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
1	NULL
(	NULL
INFR1	NULL
)	NULL
-associated	NULL
death	NULL
domain	NULL
protein	NULL
TRADD	NULL
to	NULL
mediate	NULL
NF-KB	NULL
and	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
activation	NULL
is	NULL
critical	NULL
for	NULL
long-term	NULL
lymphoblastoid	NULL
cell	NULL
proliferation	NULL
.	NULL

We	NULL
now	NULL
find	NULL
that	NULL
LMP1	NULL
signaling	NULL
through	NULL
TRADD	NULL
differs	NULL
from	NULL
TNFR1	NULL
signaling	NULL
through	NULL
TRADD	NULL
.	NULL

LMP1	NULL
needs	NULL
only	NULL
11	NULL
amino	NULL
acids	NULL
to	NULL
activate	NULL
NF-KB	NULL
or	NULL
synergize	NULL
with	NULL
TRADD	NULL
in	NULL
NF-KB	NULL
activation	NULL
,	NULL
while	NULL
TNFR1	NULL
requires	NULL
~70	NULL
residues	NULL
.	NULL

Further	NULL
,	NULL
LMP1	NULL
does	NULL
not	NULL
require	NULL
TRADD	NULL
residues	NULL
294	NULL
to	NULL
312	NULL
for	NULL
NF-KB	NULL
activation	NULL
,	NULL
while	NULL
TNFR1	NULL
requires	NULL
TRADD	NULL
residues	NULL
296	NULL
to	NULL
302	NULL
.	NULL

LMP1	NULL
is	NULL
partially	NULL
blocked	NULL
for	NULL
NF-KB	NULL
activation	NULL
by	NULL
a	NULL
TRADD	NULL
mutant	NULL
consisting	NULL
of	NULL
residues	NULL
122	NULL
to	NULL
293	NULL
.	NULL

Unlike	NULL
TNFR1	NULL
,	NULL
LMP1	NULL
can	NULL
interact	NULL
directly	NULL
with	NULL
receptor-interacting	NULL
protein	NULL
(	NULL
RIP	NULL
)	NULL
and	NULL
stably	NULL
associates	NULL
with	NULL
RIP	NULL
in	NULL
EBV-transformed	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
.	NULL

Surprisingly	NULL
,	NULL
LMP1	NULL
does	NULL
not	NULL
require	NULL
RIP	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Despite	NULL
constitutive	NULL
association	NULL
with	NULL
TRADD	NULL
or	NULL
RIP	NULL
,	NULL
LMP	NULL
does	NULL
not	NULL
induce	NULL
apoptosis	NULL
in	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
or	NULL
human	NULL
embryonic	NULL
kidney	NULL
293	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
add	NULL
a	NULL
different	NULL
perspective	NULL
to	NULL
the	NULL
molecular	NULL
interactions	NULL
through	NULL
which	NULL
LMP1	NULL
,	NULL
TRADD	NULL
,	NULL
and	NULL
RIP	NULL
participate	NULL
in	NULL
B-lymphocyte	NULL
activation	NULL
and	NULL
growth	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
EBV-mediated	NULL
growth	NULL
transformation	NULL
of	NULL
resting	NULL
primary	NULL
human	NULL
B	NULL
lymphocytes	NULL
into	NULL
indefinitely	NULL
proliferating	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCLs	NULL
)	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Genetic	NULL
and	NULL
biochemical	NULL
evidence	NULL
indicates	NULL
that	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
through	NULL
which	NULL
LMP1	NULL
mediates	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
resembles	NULL
those	NULL
of	NULL
activated	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptors	NULL
(	NULL
TNFR	NULL
)	NULL
(	NULL
26	NULL
,	NULL
28	NULL
,	NULL
31	NULL
,	NULL
43	NULL
)	NULL
.	NULL

LMP1	NULL
consists	NULL
of	NULL
a	NULL
24-amino-acid	NULL
N-terminal	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
six	NULL
transmembrane	NULL
domains	NULL
,	NULL
and	NULL
a	NULL
200-amino-acid	NULL
C-terminal	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Although	NULL
no	NULL
specific	NULL
sequence	NULL
of	NULL
the	NULL
N-terminal	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
essential	NULL
for	NULL
growth	NULL
transformation	NULL
,	NULL
the	NULL
N	NULL
terminus	NULL
fulfills	NULL
a	NULL
critical	NULL
structural	NULL
role	NULL
by	NULL
tethering	NULL
the	NULL
first	NULL
transmembrane	NULL
domain	NULL
to	NULL
the	NULL
cytoplasm	NULL
(	NULL
25	NULL
,	NULL
30	NULL
)	NULL
.	NULL

The	NULL
six	NULL
transmembrane	NULL
domains	NULL
collectively	NULL
enable	NULL
LMP1	NULL
to	NULL
self-aggregate	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
similarly	NULL
to	NULL
a	NULL
capped	NULL
receptor	NULL
.	NULL

Aggregation	NULL
of	NULL
LMP1	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
causes	NULL
two	NULL
specific	NULL
sites	NULL
within	NULL
the	NULL
C-terminal	NULL
cytoplasmic	NULL
tail	NULL
to	NULL
constitutively	NULL
mediate	NULL
essential	NULL
transforming	NULL
signals	NULL
through	NULL
association	NULL
with	NULL
proteins	NULL
that	NULL
ordinarily	NULL
mediate	NULL
li-gand-induced	NULL
signals	NULL
from	NULL
activated	NULL
TNFR	NULL
family	NULL
members	NULL
(	NULL
7	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
16	NULL
,	NULL
19	NULL
,	NULL
22	NULL
,	NULL
25	NULL
,	NULL
31	NULL
,	NULL
50	NULL
,	NULL
56	NULL
)	NULL
.	NULL

These	NULL
two	NULL
transformation	NULL
effector	NULL
sites	NULL
(	NULL
TES1	NULL
and	NULL
TES2	NULL
)	NULL
are	NULL
within	NULL
C-terminal	NULL
NF-kB	NULL
activating	NULL
regions	NULL
CTAR1	NULL
and	NULL
CTAR2	NULL
(	NULL
24	NULL
,	NULL
42	NULL
)	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Channing	NULL
Laboratories	NULL
,	NULL
181	NULL
Long-wood	NULL
Ave.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115-5804	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
617	NULL
)	NULL
525-4252	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
617	NULL
)	NULL
525-4251	NULL
.	NULL

E-mail	NULL
:	NULL
ekieff	NULL
@	NULL
rics.bwh.harvard.edu	NULL
.	NULL

i	NULL
Present	NULL
address	NULL
:	NULL
Integrated	NULL
DNA	NULL
Technologies	NULL
,	NULL
Inc.	NULL
,	NULL
Brookline	NULL
,	NULL
MA	NULL
02446	NULL
.	NULL

5759	NULL
TES1/CTAR1	NULL
(	NULL
residues	NULL
187	NULL
to	NULL
231	NULL
[	NULL
Fig	NULL
.	NULL

1	NULL
]	NULL
)	NULL
interacts	NULL
with	NULL
TNFR-associated	NULL
factors	NULL
(	NULL
TRAFs	NULL
)	NULL
and	NULL
is	NULL
sufficient	NULL
for	NULL
mediating	NULL
initial	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
(	NULL
31	NULL
,	NULL
43	NULL
)	NULL
.	NULL

TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAFS	NULL
mediate	NULL
NF-KB	NULL
activation	NULL
from	NULL
TES1/CTAR1	NULL
(	NULL
4	NULL
,	NULL
10	NULL
,	NULL
43	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
TRAF	NULL
interaction	NULL
site	NULL
results	NULL
in	NULL
EBV	NULL
recombinants	NULL
that	NULL
are	NULL
unable	NULL
to	NULL
growth	NULL
transform	NULL
primary	NULL
B	NULL
lymphocytes	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
TES1I/	NULL
CTAR1	NULL
amino	NULL
acid	NULL
sequence	NULL
is	NULL
similar	NULL
to	NULL
sites	NULL
in	NULL
CD40	NULL
and	NULL
CD30	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
NF-KB	NULL
activation	NULL
(	NULL
9	NULL
,	NULL
40	NULL
)	NULL
.	NULL

CD40	NULL
is	NULL
the	NULL
receptor	NULL
for	NULL
a	NULL
T-cell	NULL
surface	NULL
ligand	NULL
that	NULL
activates	NULL
B-lymphocyte	NULL
growth	NULL
and	NULL
differentiation	NULL
(	NULL
2	NULL
,	NULL
8	NULL
,	NULL
32	NULL
,	NULL
44	NULL
)	NULL
,	NULL
and	NULL
CD30	NULL
is	NULL
the	NULL
receptor	NULL
for	NULL
a	NULL
T-cell	NULL
surface	NULL
ligand	NULL
that	NULL
can	NULL
negatively	NULL
affect	NULL
heavy-chain	NULL
class	NULL
switching	NULL
(	NULL
5	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
retrospect	NULL
,	NULL
LMP1	NULL
mimicry	NULL
of	NULL
an	NULL
activated	NULL
TNFR	NULL
is	NULL
not	NULL
surprising	NULL
given	NULL
the	NULL
similar	NULL
effects	NULL
of	NULL
LMP1	NULL
and	NULL
CD40	NULL
on	NULL
B-lymphocyte	NULL
growth	NULL
and	NULL
gene	NULL
activation	NULL
(	NULL
2	NULL
,	NULL
8	NULL
,	NULL
9	NULL
,	NULL
23	NULL
,	NULL
29	NULL
,	NULL
32	NULL
,	NULL
44	NULL
,	NULL
47	NULL
)	NULL
.	NULL

TES2/CTAR2	NULL
is	NULL
at	NULL
the	NULL
LMP1	NULL
C	NULL
terminus	NULL
and	NULL
activates	NULL
NF-kB	NULL
through	NULL
the	NULL
TNFR1-associated	NULL
death	NULL
domain	NULL
protein	NULL
TRADD	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
adverse	NULL
consequences	NULL
of	NULL
mutation	NULL
of	NULL
the	NULL
three	NULL
C-terminal	NULL
LMP1	NULL
codons	NULL
from	NULL
YYD	NULL
to	NULL
ID	NULL
on	NULL
TRADD	NULL
interaction	NULL
in	NULL
the	NULL
yeast	NULL
Saccharomyces	NULL
cerevisiae	NULL
,	NULL
on	NULL
TRADD	NULL
association	NULL
in	NULL
mammalian	NULL
cells	NULL
,	NULL
on	NULL
NF-kB	NULL
activation	NULL
,	NULL
on	NULL
TRADD	NULL
synergy	NULL
with	NULL
LMP1	NULL
in	NULL
NF-kB	NULL
activation	NULL
,	NULL
and	NULL
on	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
link	NULL
TRADD	NULL
to	NULL
these	NULL
TES2/CTAR2	NULL
effects	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
tyrosines	NULL
are	NULL
not	NULL
specifically	NULL
required	NULL
since	NULL
substitution	NULL
with	NULL
codons	NULL
encoding	NULL
phenylala-nine	NULL
is	NULL
indistinguishable	NULL
from	NULL
wild	NULL
type	NULL
in	NULL
TRADD	NULL
association	NULL
in	NULL
lymphocytes	NULL
,	NULL
in	NULL
NF-kB	NULL
activation	NULL
,	NULL
and	NULL
in	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
this	NULL
level	NULL
of	NULL
genetic	NULL
anal-ysis	NULL
,	NULL
TES2	NULL
appears	NULL
to	NULL
coincide	NULL
with	NULL
CTAR2	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
TRADD	NULL
is	NULL
a	NULL
key	NULL
signal-transducing	NULL
intermediate	NULL
.	NULL

The	NULL
constitutive	NULL
as	NULL
5760	NULL
IZUMI	NULL
ET	NULL
AL	NULL
.	NULL

804080860686	NULL
Transformation	NULL
Effector	NULL
Site	NULL
1	NULL
Drives	NULL
initial	NULL
cell	NULL
proliferation	NULL
TRAF	NULL
association	NULL
231	NULL
Low	NULL
NF-B	NULL
activation	NULL
Transformation	NULL
Effector	NULL
Site	NULL
2	NULL
Enables	NULL
permanent	NULL
LCL	NULL
outgrowth	NULL
TRADD	NULL
and	NULL
RIP	NULL
association	NULL
High	NULL
NF-xB	NULL
activation	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Diagram	NULL
of	NULL
LMP1	NULL
.	NULL

The	NULL
Flag	NULL
epitope	NULL
was	NULL
introduced	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
.	NULL

LMP1	NULL
residues	NULL
187	NULL
,	NULL
231	NULL
,	NULL
352	NULL
,	NULL
and	NULL
386	NULL
are	NULL
marked	NULL
.	NULL

LMP1	NULL
constitutively	NULL
aggregates	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
associates	NULL
with	NULL
TRAFs	NULL
,	NULL
TRADD	NULL
,	NULL
and	NULL
RIP	NULL
.	NULL

TES1	NULL
aggregates	NULL
TRAFs	NULL
to	NULL
mediate	NULL
low-level	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
initial	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

TES2	NULL
aggregates	NULL
RIP	NULL
or	NULL
TRADD	NULL
,	NULL
both	NULL
of	NULL
which	NULL
associate	NULL
with	NULL
TRAFs	NULL
to	NULL
mediate	NULL
high-level	NULL
NF-kB	NULL
activation	NULL
and	NULL
enable	NULL
permanent	NULL
LCL	NULL
outgrowth	NULL
.	NULL

sociation	NULL
of	NULL
LMP1	NULL
with	NULL
TRADD	NULL
in	NULL
LCLs	NULL
(	NULL
28	NULL
)	NULL
contrasts	NULL
with	NULL
TNFR1	NULL
,	NULL
which	NULL
recruits	NULL
TRADD	NULL
in	NULL
response	NULL
to	NULL
ligand	NULL
binding	NULL
and	NULL
receptor	NULL
aggregation	NULL
(	NULL
22	NULL
,	NULL
21	NULL
)	NULL
.	NULL

The	NULL
objective	NULL
of	NULL
the	NULL
experiments	NULL
reported	NULL
here	NULL
was	NULL
to	NULL
investigate	NULL
further	NULL
the	NULL
biochemistry	NULL
of	NULL
LMP1	NULL
TES2/CTAR2	NULL
interaction	NULL
with	NULL
TRADD	NULL
and	NULL
the	NULL
expected	NULL
proapoptotic	NULL
effects	NULL
.	NULL

Since	NULL
receptor-interacting	NULL
protein	NULL
(	NULL
RIP	NULL
)	NULL
is	NULL
implicated	NULL
in	NULL
TNFR1	NULL
and	NULL
TRADD-mediated	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
apoptosis	NULL
(	NULL
20	NULL
,	NULL
33	NULL
,	NULL
51	NULL
,	NULL
54	NULL
)	NULL
,	NULL
we	NULL
also	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
RIP	NULL
in	NULL
TES2/CTAR2-mediated	NULL
signaling	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Viruses	NULL
,	NULL
cells	NULL
,	NULL
and	NULL
DNA	NULL
clones	NULL
.	NULL

SVT35	NULL
Jurkat	NULL
T-lymphoma	NULL
cells	NULL
and	NULL
RIP-deficient	NULL
35.3.13	NULL
cells	NULL
(	NULL
54	NULL
)	NULL
were	NULL
cultivated	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
in	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Gemini	NULL
)	NULL
supplemented	NULL
with	NULL
penicillin-streptomycin	NULL
and	NULL
glutamine	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

RIP	NULL
vector	NULL
pRK-F-RIP	NULL
,	NULL
a	NULL
gift	NULL
from	NULL
David	NULL
Goeddel	NULL
(	NULL
Tularik	NULL
)	NULL
(	NULL
20	NULL
)	NULL
,	NULL
was	NULL
transferred	NULL
to	NULL
peDNA3	NULL
in	NULL
order	NULL
to	NULL
Myc	NULL
tag	NULL
the	NULL
protein	NULL
.	NULL

Lymphoblastoid	NULL
and	NULL
human	NULL
embryonic	NULL
kidney	NULL
293	NULL
(	NULL
HEK293	NULL
)	NULL
cell	NULL
lines	NULL
are	NULL
described	NULL
elsewhere	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

N-terminally	NULL
Flag-tagged	NULL
LMP-1	NULL
(	NULL
F-LMP1	NULL
)	NULL
expression	NULL
vectors	NULL
were	NULL
derived	NULL
by	NULL
endonuclease	NULL
deletion	NULL
or	NULL
codon	NULL
insertions	NULL
as	NULL
described	NULL
before	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Yeast	NULL
two-hybrid	NULL
assay	NULL
.	NULL

The	NULL
methods	NULL
used	NULL
for	NULL
cell	NULL
culture	NULL
,	NULL
yeast	NULL
transformation	NULL
,	NULL
and	NULL
B-galactosidase	NULL
detection	NULL
in	NULL
S.	NULL
cerevisiae	NULL
Y190	NULL
are	NULL
described	NULL
elsewhere	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
DBD	NULL
)	NULL
-LMP1	NULL
fusions	NULL
are	NULL
derived	NULL
from	NULL
F-LMP1	NULL
clones	NULL
(	NULL
see	NULL
above	NULL
)	NULL
or	NULL
from	NULL
a	NULL
prior	NULL
study	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
Gal4-activation	NULL
domain	NULL
(	NULL
AD	NULL
)	NULL
-RIP	NULL
fusion	NULL
was	NULL
derived	NULL
from	NULL
pRK-F-RIP	NULL
subcloned	NULL
into	NULL
pACTIL	NULL
Coimmunoprecipitation	NULL
analyses	NULL
.	NULL

Analyses	NULL
were	NULL
done	NULL
with	NULL
an	NULL
M2	NULL
affinity	NULL
gel	NULL
(	NULL
Kodak	NULL
)	NULL
as	NULL
before	NULL
(	NULL
9	NULL
,	NULL
26	NULL
)	NULL
except	NULL
that	NULL
immunoblots	NULL
were	NULL
analyzed	NULL
with	NULL
RIP	NULL
antibody	NULL
(	NULL
Pharmingen	NULL
)	NULL
.	NULL

NF-xB	NULL
activation	NULL
.	NULL

3x-xB-L	NULL
luciferase	NULL
reporter	NULL
and	NULL
mut-kB-L	NULL
negative	NULL
control	NULL
were	NULL
gifts	NULL
from	NULL
Tom	NULL
Mitchell	NULL
and	NULL
Bill	NULL
Sugden	NULL
(	NULL
University	NULL
of	NULL
Wisconsin	NULL
,	NULL
Madi-son	NULL
)	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Methods	NULL
for	NULL
electroporation	NULL
and	NULL
analysis	NULL
are	NULL
described	NULL
elsewhere	NULL
(	NULL
9	NULL
,	NULL
26	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Apoptosis	NULL
assays	NULL
.	NULL

BJAB	NULL
cells	NULL
were	NULL
electroporated	NULL
as	NULL
before	NULL
(	NULL
10	NULL
)	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
LMP1	NULL
vector	NULL
DNA	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
green	NULL
fluorescent	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
vector	NULL
pEGFP	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

Dead	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
Ficoll-Hypaque	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Viable	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
10	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
cycloheximide	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

Next	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
permeabilized	NULL
with	NULL
70	NULL
%	NULL
ethanol	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
DNA	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
propidium	NULL
iodide	NULL
(	NULL
Mo-lecular	NULL
Probes	NULL
)	NULL
per	NULL
ml	NULL
in	NULL
Dulbecco	NULL
's	NULL
phosphate-buffered	NULL
saline	NULL
PBS	NULL
(	NULL
Gibco	NULL
)	NULL
with	NULL
1	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
0.2	NULL
mg	NULL
of	NULL
RNase	NULL
A	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
DNA	NULL
content	NULL
of	NULL
GFP-positive	NULL
cells	NULL
was	NULL
quantitated	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
(	NULL
Becton	NULL
Dickinson	NULL
FACS	NULL
Calibur	NULL
)	NULL
.	NULL

HEK293	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
cotransfected	NULL
by	NULL
using	NULL
Superfect	NULL
(	NULL
Qiagen	NULL
)	NULL
with	NULL
2	NULL
g	NULL
of	NULL
peDNA3	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
peDNA3	NULL
LMP1	NULL
vector	NULL
DNA	NULL
,	NULL
or	NULL
peDNA3	NULL
F-LMPA188-352	NULL
(	NULL
41	NULL
)	NULL
and	NULL
with	NULL
0.35	NULL
pg	NULL
of	NULL
3x-	NULL
«	NULL
B-L	NULL
NF-kB	NULL
,	NULL
0.35	NULL
ug	NULL
of	NULL
pGK-B-galactosidase	NULL
,	NULL
and	NULL
where	NULL
indicated	NULL
0.25	NULL
pg	NULL
of	NULL
nondegradable	NULL
I-kB	NULL
«	NULL
vector	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

pCMV4	NULL
I-xBa	NULL
$	NULL
;	NULL
;	NULL
,	NULL
A8	NULL
;	NULL
5A	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dean	NULL
Ballard	NULL
,	NULL
Vanderbilt	NULL
University	NULL
)	NULL
(	NULL
6	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
with	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
stained	NULL
for	NULL
B-galactosi-dase	NULL
,	NULL
and	NULL
photographed	NULL
.	NULL

A	NULL
duplicate	NULL
was	NULL
tested	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
NF-kB	NULL
reporter	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
Western	NULL
immunoblotting	NULL
for	NULL
LMP1	NULL
with	NULL
$	NULL
12	NULL
and	NULL
MS	NULL
antibodies	NULL
(	NULL
Kodak	NULL
)	NULL
as	NULL
described	NULL
before	NULL
(	NULL
9	NULL
,	NULL
26	NULL
)	NULL
.	NULL

RESULTS	NULL
LMP1	NULL
residues	NULL
376	NULL
to	NULL
386	NULL
engage	NULL
TRADD	NULL
to	NULL
mediate	NULL
NF-KB	NULL
activation	NULL
.	NULL

TRADD	NULL
interaction	NULL
with	NULL
LMP1	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
the	NULL
result	NULL
of	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
screen	NULL
with	NULL
LMP1	NULL
amino	NULL
acids	NULL
355	NULL
to	NULL
386	NULL
(	NULL
28	NULL
)	NULL
.	NULL

A	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
delineate	NULL
more	NULL
precisely	NULL
the	NULL
TES2/CTAR2	NULL
residues	NULL
(	NULL
355	NULL
to	NULL
386	NULL
[	NULL
Fig	NULL
.	NULL

1	NULL
]	NULL
)	NULL
required	NULL
for	NULL
TRADD	NULL
interaction	NULL
.	NULL

LMP1	NULL
amino	NULL
acids	NULL
182	NULL
to	NULL
386	NULL
comprising	NULL
TES1/CTAR1	NULL
and	NULL
TES2/CTAR2	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
Gal4	NULL
DBD	NULL
so	NULL
that	NULL
interaction	NULL
of	NULL
TES1/CTAR1	NULL
with	NULL
a	NULL
Gal4	NULL
AD-TRAF3	NULL
fusion	NULL
could	NULL
serve	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
bait	NULL
expression	NULL
.	NULL

TRADD	NULL
interacted	NULL
with	NULL
the	NULL
LMP1	NULL
bait	NULL
at	NULL
a	NULL
substantially	NULL
lower	NULL
level	NULL
than	NULL
TRAF3	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
amino	NULL
acids	NULL
356	NULL
to	NULL
365	NULL
,	NULL
366	NULL
to	NULL
371	NULL
,	NULL
or	NULL
372	NULL
to	NULL
375	NULL
(	NULL
in	NULL
F-LMP1A356-365	NULL
,	NULL
F-LMP1A366-371	NULL
,	NULL
or	NULL
F-LMP1A372-375	NULL
)	NULL
did	NULL
not	NULL
substantially	NULL
weaken	NULL
TRADD	NULL
interaction	NULL
,	NULL
whereas	NULL
deletion	NULL
of	NULL
amino	NULL
acids	NULL
374	NULL
to	NULL
386	NULL
abrogated	NULL
TRADD	NULL
interaction	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
Y354	NULL
YD38e-to-ID	NULL
mutation	NULL
(	NULL
in	NULL
F-LMP1AID	NULL
)	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

None	NULL
of	NULL
these	NULL
deletions	NULL
affected	NULL
TRAF3	NULL
interaction	NULL
.	NULL

Since	NULL
LMP1	NULL
amino	NULL
acids	NULL
355	NULL
to	NULL
386	NULL
are	NULL
sufficient	NULL
for	NULL
TRADD	NULL
interaction	NULL
and	NULL
residues	NULL
356	NULL
to	NULL
365	NULL
,	NULL
366	NULL
to	NULL
371	NULL
,	NULL
or	NULL
372	NULL
to	NULL
375	NULL
are	NULL
not	NULL
critical	NULL
,	NULL
the	NULL
critical	NULL
residues	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
from	NULL
positions	NULL
376	NULL
to	NULL
386	NULL
.	NULL

To	NULL
correlate	NULL
the	NULL
TRADD-LMP1	NULL
interaction	NULL
in	NULL
yeast	NULL
cells	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
mammalian	NULL
cells	NULL
,	NULL
an	NULL
F-LMP1	NULL
TES2/	NULL
CTAR2	NULL
expression	NULL
vector	NULL
,	NULL
F-LMP1A	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
fusing	NULL
codons	NULL
352	NULL
to	NULL
386	NULL
in	NULL
frame	NULL
with	NULL
and	NULL
3	NULL
'	NULL
to	NULL
codons	NULL
encoding	NULL
the	NULL
LMP1	NULL
amino	NULL
terminus	NULL
and	NULL
six	NULL
transmembrane	NULL
domains	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

F-LMP1A	NULL
and	NULL
TRADD	NULL
are	NULL
potent	NULL
activators	NULL
of	NULL
NF-kB	NULL
in	NULL
HEK293	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
yeast	NULL
data	NULL
,	NULL
deletion	NULL
of	NULL
residues	NULL
356	NULL
to	NULL
365	NULL
,	NULL
366	NULL
to	NULL
372	NULL
,	NULL
or	NULL
373	NULL
to	NULL
375	NULL
had	NULL
minimal	NULL
effect	NULL
on	NULL
F-LMP1A-mediated	NULL
NF-KB	NULL
activation	NULL
,	NULL
whereas	NULL
deletion	NULL
of	NULL
residues	NULL
374	NULL
to	NULL
386	NULL
or	NULL
mutation	NULL
of	NULL
the	NULL
terminal	NULL
Y	NULL
;	NULL
5	NULL
,	NULL
YD	NULL
;	NULL
g	NULL
,	NULL
residues	NULL
to	NULL
ID	NULL
did	NULL
not	NULL
activate	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

TRADD	NULL
overexpression	NULL
activated	NULL
NF-kB	NULL
and	NULL
synergistically	NULL
activated	NULL
NF-kB	NULL
with	NULL
F-LMP1A356-365	NULL
,	NULL
F-LMP1A366-372	NULL
,	NULL
or	NULL
F-LMP1A373-375	NULL
vectors	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
TRADD	NULL
overexpression	NULL
increases	NULL
TRADD	NULL
concentration	NULL
and	NULL
TRADD	NULL
association	NULL
with	NULL
LMP1	NULL
,	NULL
resulting	NULL
in	NULL
synergistic	NULL
NF-kB	NULL
activation	NULL
.	NULL

No	NULL
synergy	NULL
was	NULL
found	NULL
with	NULL
F-LMP1A374-386	NULL
or	NULL
for	NULL
F-LMP1AID	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
LMP1	NULL
amino	NULL
acids	NULL
TABLE	NULL
1	NULL
.	NULL

LMP1	NULL
interaction	NULL
with	NULL
TRADD	NULL
and	NULL
TRAF3	NULL
in	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
``	NULL
Gal4	NULL
DBD-LMP1	NULL
Interaction	NULL
with	NULL
:	NULL
(	NULL
codons	NULL
of	NULL
LMP1	NULL
)	NULL
Gal4	NULL
AD-TRADD	NULL
Gal4	NULL
AD-TRAF3	NULL
182-386	NULL
+	NULL
++	NULL
182-386A356-365	NULL
+	NULL
++	NULL
182-386A366-371	NULL
+	NULL
++	NULL
182-386A372-375	NULL
+	NULL
++	NULL
182-373	NULL
-	NULL
++	NULL
182-383ID	NULL
-	NULL
++	NULL
``	NULL
S.	NULL
cerevisiae	NULL
Y¥190	NULL
was	NULL
transformed	NULL
with	NULL
pAS1	NULL
vectors	NULL
expressing	NULL
the	NULL
Gal4	NULL
DBD	NULL
fused	NULL
to	NULL
the	NULL
indicated	NULL
codons	NULL
of	NULL
LMP1	NULL
and	NULL
pACT	NULL
vectors	NULL
expressing	NULL
the	NULL
Gal4	NULL
AD	NULL
fused	NULL
to	NULL
TRADD	NULL
codons	NULL
195	NULL
to	NULL
312	NULL
or	NULL
TRAF3	NULL
codons	NULL
312	NULL
to	NULL
568	NULL
.	NULL

Transformed	NULL
yeast	NULL
cells	NULL
were	NULL
selected	NULL
on	NULL
medium	NULL
lacking	NULL
tryptophan	NULL
and	NULL
leucine	NULL
.	NULL

Colonies	NULL
were	NULL
transferred	NULL
to	NULL
filters	NULL
and	NULL
lysed	NULL
by	NULL
freeze-thawing	NULL
,	NULL
and	NULL
B-galactosidase	NULL
was	NULL
detected	NULL
with	NULL
X-Gal	NULL
.	NULL

Blue	NULL
colonies	NULL
after	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
were	NULL
scored	NULL
++	NULL
,	NULL
and	NULL
light	NULL
blue	NULL
colonies	NULL
were	NULL
scored	NULL
+	NULL
.	NULL

Yeast	NULL
cells	NULL
transformed	NULL
with	NULL
these	NULL
Gal4	NULL
DBD-LMP1	NULL
DNAs	NULL
alone	NULL
scored	NULL
negative	NULL
for	NULL
B-galactosidase	NULL
.	NULL

Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
A	NULL
140-7	NULL
Fold	NULL
Activation	NULL
NF-xB	NULL
in	NULL
HEK293	NULL
TRADD	NULL
-	NULL
4	NULL
-	NULL
#	NULL
-	NULL
4	NULL
-	NULL
$	NULL
-	NULL
40	NULL
>	NULL
4	NULL
-	NULL
o+	NULL
he	NULL
o	NULL
FLmpia	NULL
$	NULL
°	NULL
&	NULL
€	NULL
p	NULL
Ro	NULL
@	NULL
=	NULL
2	NULL
i	NULL
5	NULL
Mo	NULL
®	NULL
3	NULL
§	NULL
§	NULL
§	NULL
f	NULL
z	NULL
-	NULL
4	NULL
-	NULL
4	NULL
4	NULL
-	NULL
4	NULL
B	NULL
507	NULL
0050-	NULL
&	NULL
ab	NULL
o	NULL
]	NULL
5	NULL
{	NULL
a	NULL
40	NULL
¥	NULL
1	NULL
LL	NULL
B	NULL
z	NULL
1	NULL
<	NULL
30	NULL
2	NULL
{	NULL
Eo	NULL
1	NULL
2	NULL
1	NULL
s	NULL
3	NULL
20-s	NULL
-	NULL
I	NULL
2	NULL
I	NULL
10	NULL
-o-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-o	NULL
+	NULL
-	NULL
+	NULL
Ses	NULL
LO	NULL
<	NULL
<	NULL
L0	NULL
._	NULL
L	NULL
C	NULL
-~	NULL
mom	NULL
Tom	NULL
5	NULL
5	NULL
~	NULL
75	NULL
%	NULL
-	NULL
75	NULL
LL	NULL
ul	NULL
-	NULL
4	NULL
t-	NULL
4	NULL
4	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Characterization	NULL
of	NULL
the	NULL
LMP1	NULL
residues	NULL
critical	NULL
for	NULL
engaging	NULL
TRADD	NULL
to	NULL
synergistically	NULL
activate	NULL
NF-kB	NULL
.	NULL

Five	NULL
million	NULL
HEK293	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
pSGS	NULL
or	NULL
TES2/CTAR2	NULL
vector	NULL
F-LMP1A	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
TRADD	NULL
vector	NULL
where	NULL
indicated	NULL
,	NULL
2.5	NULL
pg	NULL
of	NULL
3x-kB-L	NULL
luciferase	NULL
reporter	NULL
,	NULL
which	NULL
has	NULL
three	NULL
copies	NULL
of	NULL
a	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
kB	NULL
element	NULL
and	NULL
minimal	NULL
fos	NULL
promoter	NULL
,	NULL
and	NULL
2.5	NULL
pg	NULL
of	NULL
glucokinase	NULL
promoter/B-galactosidase	NULL
reporter	NULL
to	NULL
monitor	NULL
transfection	NULL
efficiency	NULL
;	NULL
18	NULL
h	NULL
later	NULL
,	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
luciferase	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
B-galactosidase	NULL
(	NULL
Tropix	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufactur-ers	NULL
'	NULL
directions	NULL
on	NULL
an	NULL
Opticomp	NULL
I	NULL
luminometer	NULL
.	NULL

The	NULL
base	NULL
wild-type	NULL
F-LMP1A	NULL
vector	NULL
is	NULL
deleted	NULL
for	NULL
residues	NULL
187	NULL
to	NULL
351	NULL
.	NULL

Further	NULL
deletions	NULL
are	NULL
indicated	NULL
.	NULL

ID	NULL
indicates	NULL
mutation	NULL
of	NULL
the	NULL
terminal	NULL
residues	NULL
Y35	NULL
,	NULL
YD35	NULL
,	NULL
to	NULL
ID	NULL
.	NULL

Standard	NULL
error	NULL
of	NULL
means	NULL
are	NULL
reported	NULL
.	NULL

In	NULL
data	NULL
not	NULL
shown	NULL
,	NULL
protein	NULL
levels	NULL
of	NULL
TRADD	NULL
or	NULL
LMP1	NULL
mutants	NULL
were	NULL
equivalent	NULL
in	NULL
separate	NULL
transfections	NULL
as	NULL
analyzed	NULL
by	NULL
Western	NULL
im-munoblotting	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
11	NULL
terminal	NULL
residues	NULL
of	NULL
LMP1	NULL
are	NULL
sufficient	NULL
to	NULL
engage	NULL
TRADD	NULL
to	NULL
synergistically	NULL
activate	NULL
NF-kB	NULL
.	NULL

F-LMP1	NULL
vectors	NULL
deleted	NULL
for	NULL
residues	NULL
187	NULL
to	NULL
375	NULL
or	NULL
with	NULL
a	NULL
short	NULL
stuffer	NULL
consisting	NULL
of	NULL
residues	NULL
HGHLGASLQY	NULL
inserted	NULL
between	NULL
residues	NULL
186	NULL
and	NULL
376	NULL
were	NULL
electroporated	NULL
into	NULL
HEK293	NULL
cells	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
A	NULL
.	NULL

374	NULL
to	NULL
386	NULL
are	NULL
critical	NULL
for	NULL
TES2/CTAR2-mediated	NULL
NF-kB	NULL
activation	NULL
and	NULL
for	NULL
synergy	NULL
with	NULL
TRADD	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
LMP1	NULL
residues	NULL
376	NULL
to	NULL
386	NULL
are	NULL
sufficient	NULL
for	NULL
TRADD	NULL
interaction	NULL
and	NULL
NF-kB	NULL
activation	NULL
,	NULL
codons	NULL
for	NULL
these	NULL
LMP1	NULL
SIGNALS	NULL
TRANSFORMATION	NULL
THROUGH	NULL
TRADD	NULL
AND	NULL
RIP	NULL
_	NULL
5761	NULL
residues	NULL
were	NULL
cloned	NULL
in	NULL
frame	NULL
and	NULL
3	NULL
'	NULL
to	NULL
codons	NULL
for	NULL
the	NULL
LMP1	NULL
N	NULL
terminus	NULL
and	NULL
six	NULL
membrane-spanning	NULL
domains	NULL
to	NULL
create	NULL
F-LMP1A187-375	NULL
.	NULL

When	NULL
transfected	NULL
into	NULL
HEK293	NULL
cells	NULL
,	NULL
F-LMP1A187-375	NULL
did	NULL
not	NULL
activate	NULL
NF-kB	NULL
or	NULL
synergize	NULL
with	NULL
TRADD	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
inactivity	NULL
of	NULL
the	NULL
terminal	NULL
11	NULL
amino	NULL
acids	NULL
could	NULL
be	NULL
due	NULL
to	NULL
their	NULL
proximity	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
,	NULL
we	NULL
tested	NULL
another	NULL
construct	NULL
that	NULL
has	NULL
a	NULL
10-amino-acid	NULL
stuffer	NULL
(	NULL
HGHLGASLQY	NULL
)	NULL
inserted	NULL
between	NULL
the	NULL
last	NULL
transmembrane	NULL
domain	NULL
and	NULL
amino	NULL
acids	NULL
376	NULL
to	NULL
386	NULL
.	NULL

This	NULL
construct	NULL
,	NULL
F-LMP1A187-375+stuffer	NULL
,	NULL
induced	NULL
almost	NULL
50	NULL
%	NULL
of	NULL
the	NULL
NF-kB	NULL
activity	NULL
of	NULL
F-LMP1A	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
F-LMP1A187-375+	NULL
stuffer	NULL
synergized	NULL
with	NULL
TRADD	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
conveyed	NULL
70	NULL
%	NULL
of	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
F-LMP1IA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
C-terminal	NULL
11	NULL
amino	NULL
acids	NULL
are	NULL
sufficient	NULL
for	NULL
TRADD	NULL
interaction	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

LMP1	NULL
can	NULL
synergize	NULL
with	NULL
TRADD	NULL
mutants	NULL
that	NULL
are	NULL
unable	NULL
to	NULL
engage	NULL
TRAFs	NULL
or	NULL
efficiently	NULL
interact	NULL
with	NULL
the	NULL
TNFR1	NULL
death	NULL
domain	NULL
.	NULL

The	NULL
TRADD	NULL
cDNA	NULL
clone	NULL
that	NULL
interacted	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
screen	NULL
with	NULL
LMP1	NULL
residues	NULL
355	NULL
to	NULL
386	NULL
consists	NULL
of	NULL
amino	NULL
acids	NULL
195	NULL
to	NULL
312	NULL
and	NULL
comprises	NULL
the	NULL
entire	NULL
TRADD	NULL
death	NULL
domain	NULL
(	NULL
22	NULL
,	NULL
28	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
a	NULL
smaller	NULL
TRADD	NULL
sequence	NULL
could	NULL
interact	NULL
with	NULL
LMP1	NULL
,	NULL
TRADD	NULL
deletion	NULL
mutations	NULL
were	NULL
tested	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
synergize	NULL
with	NULL
LMP1	NULL
in	NULL
NF-kB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

TRADD	NULL
1-293	NULL
is	NULL
competent	NULL
for	NULL
TRAF	NULL
interactions	NULL
and	NULL
for	NULL
some	NULL
death	NULL
domain	NULL
interactions	NULL
but	NULL
is	NULL
markedly	NULL
diminished	NULL
in	NULL
TNFR1	NULL
death	NULL
domain	NULL
interaction	NULL
and	NULL
self-aggregation-mediated	NULL
NF-kB	NULL
activation	NULL
(	NULL
22	NULL
,	NULL
45	NULL
)	NULL
.	NULL

TRADD	NULL
122-312	NULL
is	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
TRAFs	NULL
but	NULL
has	NULL
a	NULL
complete	NULL
death	NULL
domain	NULL
that	NULL
can	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
when	NULL
overexpressed	NULL
.	NULL

TRADD	NULL
122-293	NULL
is	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
TRAFs	NULL
and	NULL
has	NULL
an	NULL
incomplete	NULL
death	NULL
domain	NULL
that	NULL
cripples	NULL
TNFR1	NULL
interaction	NULL
or	NULL
self-aggregation-mediated	NULL
NF-KB	NULL
activation	NULL
(	NULL
22	NULL
,	NULL
45	NULL
)	NULL
.	NULL

While	NULL
it	NULL
was	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
more	NULL
than	NULL
50	NULL
%	NULL
deficient	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
TRADD	NULL
lacking	NULL
residues	NULL
294	NULL
to	NULL
312	NULL
(	NULL
TRADD	NULL
1-293	NULL
)	NULL
retained	NULL
70	NULL
%	NULL
of	NULL
wild-type	NULL
TRADD	NULL
syn-	NULL
50	NULL
pe	NULL
1	NULL
g	NULL
40-m	NULL
)	NULL
[	NULL
IL	NULL
I	NULL
5	NULL
-A	NULL
m	NULL
-	NULL
30	NULL
>	NULL
|£	NULL
u	NULL
I	NULL
z	NULL
=	NULL
.	NULL

3	NULL
20	NULL
5	NULL
.	NULL

2	NULL
5	NULL
|	NULL
<	NULL
I	NULL
3	NULL
10-7	NULL
0	NULL
B	NULL
LL	NULL
4	NULL
o-F-LMP1A	NULL
|-	NULL
0	NULL
+00	NULL
-o	NULL
+0	NULL
-o	NULL
4	NULL
&	NULL
0	NULL
co	NULL
o	NULL
#	NULL
&	NULL
co	NULL
oo+	NULL
TRADD	NULL
none	NULL
1-312	NULL
1-293	NULL
122-312	NULL
122-293	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

LMP1	NULL
synergistically	NULL
activates	NULL
NF-kB	NULL
with	NULL
TRADD	NULL
mutants	NULL
that	NULL
are	NULL
unable	NULL
to	NULL
engage	NULL
TRAFs	NULL
or	NULL
efficiently	NULL
interact	NULL
with	NULL
the	NULL
TNFR1	NULL
death	NULL
domain	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
full-length	NULL
TRADD	NULL
1-312	NULL
vector	NULL
DNA	NULL
,	NULL
30	NULL
pg	NULL
of	NULL
TRADD	NULL
1-293	NULL
DNA	NULL
(	NULL
crippled	NULL
for	NULL
death	NULL
domain	NULL
association	NULL
)	NULL
,	NULL
15	NULL
g	NULL
of	NULL
TRADD	NULL
122-312	NULL
DNA	NULL
(	NULL
crippled	NULL
for	NULL
TRAF2	NULL
aggregation	NULL
)	NULL
,	NULL
or	NULL
15	NULL
pg	NULL
of	NULL
TRADD	NULL
122-293	NULL
DNA	NULL
was	NULL
cotransfected	NULL
with	NULL
30	NULL
pg	NULL
of	NULL
pSGS	NULL
or	NULL
TES2/CTARZ	NULL
vector	NULL
F-LMPIA	NULL
into	NULL
HEK293	NULL
cells	NULL
along	NULL
with	NULL
NF-kB	NULL
and	NULL
B-galactosidase	NULL
reporter	NULL
DNAs	NULL
;	NULL
analysis	NULL
and	NULL
reporting	NULL
of	NULL
data	NULL
are	NULL
as	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

LMP1	NULL
and	NULL
TRADD	NULL
protein	NULL
levels	NULL
monitored	NULL
by	NULL
Western	NULL
immunoblotting	NULL
were	NULL
equivalent	NULL
between	NULL
the	NULL
individual	NULL
transfections	NULL
.	NULL

5762	NULL
IZUMI	NULL
ET	NULL
AL	NULL
.	NULL

TABLE	NULL
2	NULL
.	NULL

LMP1	NULL
interaction	NULL
with	NULL
RIP	NULL
and	NULL
TRAF3	NULL
in	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
``	NULL
Gal4	NULL
DBD-LMP1	NULL
Interaction	NULL
with	NULL
:	NULL
(	NULL
codons	NULL
of	NULL
LMP1	NULL
)	NULL
Gal4	NULL
AD-RIP	NULL
Gal4	NULL
AD-TRAF3	NULL
182-386	NULL
+	NULL
++	NULL
182-383ID	NULL
+/-	NULL
++	NULL
182-386A185-211	NULL
+	NULL
182-386A212-240	NULL
+	NULL
Not	NULL
done	NULL
187-231	NULL
-	NULL
++	NULL
355-386	NULL
-	NULL
``	NULL
S.	NULL
cerevisiae	NULL
Y¥190	NULL
was	NULL
transformed	NULL
with	NULL
pAS1	NULL
vectors	NULL
expressing	NULL
the	NULL
Gal4	NULL
DBD	NULL
fused	NULL
to	NULL
the	NULL
indicated	NULL
codons	NULL
of	NULL
LMP1	NULL
and	NULL
pACT	NULL
vectors	NULL
expressing	NULL
the	NULL
GAL4	NULL
AD	NULL
fused	NULL
to	NULL
RIP	NULL
codons	NULL
1	NULL
to	NULL
671	NULL
or	NULL
TRAF3	NULL
codons	NULL
312	NULL
to	NULL
568	NULL
.	NULL

Transformed	NULL
yeast	NULL
cells	NULL
were	NULL
selected	NULL
on	NULL
medium	NULL
lacking	NULL
tryptophan	NULL
and	NULL
leucine	NULL
.	NULL

Colonies	NULL
were	NULL
transferred	NULL
to	NULL
filters	NULL
and	NULL
lysed	NULL
by	NULL
freeze	NULL
thawing	NULL
,	NULL
and	NULL
B-galactosidase	NULL
was	NULL
detected	NULL
with	NULL
X-Gal	NULL
.	NULL

Blue	NULL
colonies	NULL
after	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
were	NULL
scored	NULL
++	NULL
,	NULL
and	NULL
light	NULL
blue	NULL
colonies	NULL
were	NULL
scored	NULL
+	NULL
.	NULL

Yeast	NULL
cells	NULL
transformed	NULL
with	NULL
these	NULL
Gal4-DBD	NULL
LMP1	NULL
DNAs	NULL
alone	NULL
scored	NULL
negative	NULL
for	NULL
B-galactosidase	NULL
.	NULL

ergy	NULL
with	NULL
LMP1	NULL
TES2/CTAR2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

LMP1	NULL
TES2/CTAR2	NULL
synergized	NULL
even	NULL
better	NULL
with	NULL
TRADD	NULL
122-312	NULL
despite	NULL
the	NULL
inability	NULL
of	NULL
TRADD	NULL
122-312	NULL
to	NULL
directly	NULL
recruit	NULL
TRAFs	NULL
.	NULL

Since	NULL
a	NULL
dominant	NULL
negative	NULL
TRAF2	NULL
can	NULL
block	NULL
TES2/CTAR2	NULL
induction	NULL
of	NULL
TES2/CTAR2	NULL
and	NULL
TRADD	NULL
synergy	NULL
in	NULL
NF-kB	NULL
activation	NULL
(	NULL
28	NULL
)	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
TRADD	NULL
122-312	NULL
can	NULL
aggregate	NULL
with	NULL
wild-type	NULL
TRADD	NULL
,	NULL
RIP	NULL
,	NULL
or	NULL
other	NULL
proteins	NULL
that	NULL
can	NULL
recruit	NULL
TRAFs	NULL
(	NULL
20	NULL
,	NULL
33	NULL
,	NULL
51	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
TRADD	NULL
122-293	NULL
,	NULL
which	NULL
lacks	NULL
a	NULL
complete	NULL
death	NULL
domain	NULL
and	NULL
can	NULL
not	NULL
interact	NULL
with	NULL
TRAFs	NULL
,	NULL
failed	NULL
to	NULL
activate	NULL
NF-kB	NULL
and	NULL
reduced	NULL
LMP1	NULL
TES2/	NULL
CTAR2-mediated	NULL
NF-KB	NULL
activation	NULL
by	NULL
about	NULL
30	NULL
%	NULL
.	NULL

This	NULL
dominant	NULL
negative	NULL
effect	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
TRADD	NULL
signaling	NULL
from	NULL
TES2/CTAR2	NULL
requires	NULL
the	NULL
ability	NULL
of	NULL
TRADD	NULL
to	NULL
recruit	NULL
TRAFs	NULL
or	NULL
other	NULL
proteins	NULL
that	NULL
can	NULL
recruit	NULL
TRAFs	NULL
.	NULL

Deletion	NULL
of	NULL
TRADD	NULL
residues	NULL
294	NULL
to	NULL
312	NULL
probably	NULL
compromises	NULL
recruitment	NULL
of	NULL
death	NULL
domain	NULL
proteins	NULL
that	NULL
can	NULL
recruit	NULL
TRAF2	NULL
,	NULL
while	NULL
the	NULL
deletion	NULL
of	NULL
residues	NULL
1	NULL
to	NULL
121	NULL
abrogates	NULL
direct	NULL
TRAF	NULL
recruitment	NULL
.	NULL

RIP	NULL
interacts	NULL
with	NULL
LMP1	NULL
.	NULL

The	NULL
potential	NULL
interaction	NULL
of	NULL
RIP	NULL
with	NULL
LMP1	NULL
was	NULL
evaluated	NULL
in	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
in	NULL
comparison	NULL
with	NULL
TRAF3	NULL
and	NULL
TRADD	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

RIP	NULL
interacted	NULL
directly	NULL
with	NULL
LMP1	NULL
residues	NULL
182	NULL
to	NULL
386	NULL
,	NULL
and	NULL
mutation	NULL
of	NULL
the	NULL
LMP1	NULL
C-terminal	NULL
Y35	NULL
,	NULL
YD	NULL
;	NULL
35	NULL
,	NULL
to	NULL
ID	NULL
weakened	NULL
RIP	NULL
interaction	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
LMP1	NULL
with	NULL
RIP	NULL
was	NULL
somewhat	NULL
weaker	NULL
than	NULL
that	NULL
with	NULL
TRADD	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
deletion	NULL
of	NULL
LMP1	NULL
residues	NULL
185	NULL
to	NULL
211	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
core	NULL
TRAF	NULL
binding	NULL
site	NULL
,	NULL
abrogated	NULL
TRAF3	NULL
interaction	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
RIP	NULL
interaction	NULL
.	NULL

Moreover	NULL
,	NULL
RIP	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
residues	NULL
187	NULL
to	NULL
231	NULL
whereas	NULL
TRAF3	NULL
bound	NULL
efficiently	NULL
to	NULL
residues	NULL
187	NULL
to	NULL
231	NULL
.	NULL

Surprisingly	NULL
,	NULL
RIP	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
LMP1	NULL
amino	NULL
acids	NULL
355	NULL
to	NULL
386	NULL
although	NULL
this	NULL
sequence	NULL
is	NULL
sufficient	NULL
for	NULL
TRADD	NULL
interaction	NULL
(	NULL
28	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
RIP	NULL
interacts	NULL
with	NULL
LMP1	NULL
,	NULL
probably	NULL
through	NULL
TES2/CTAR2	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
adverse	NULL
effect	NULL
of	NULL
the	NULL
YYD-to-ID	NULL
mutation	NULL
,	NULL
but	NULL
with	NULL
a	NULL
broader	NULL
or	NULL
different	NULL
sequence	NULL
requirement	NULL
than	NULL
TRADD	NULL
.	NULL

We	NULL
further	NULL
investigated	NULL
RIP	NULL
,	NULL
TRADD	NULL
,	NULL
and	NULL
TRAF3	NULL
binding	NULL
to	NULL
LMP1	NULL
by	NULL
doubly	NULL
transforming	NULL
yeast	NULL
with	NULL
Gal4	NULL
DBD-LMP1	NULL
C-terminal	NULL
tail	NULL
vectors	NULL
as	NULL
bait	NULL
and	NULL
Gal4	NULL
AD-RIP	NULL
,	NULL
-TRADD	NULL
,	NULL
and	NULL
-TRAF3	NULL
fusion	NULL
protein	NULL
expression	NULL
vectors	NULL
as	NULL
prey	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
interaction	NULL
was	NULL
then	NULL
assayed	NULL
by	NULL
in	NULL
situ	NULL
5-bromo-4-chloro-3-indolyl-B-p-galactopyranoside	NULL
(	NULL
X-Gal	NULL
)	NULL
color	NULL
conversion	NULL
using	NULL
doubly	NULL
selected	NULL
,	NULL
actively	NULL
growing	NULL
individual	NULL
yeast	NULL
colonies	NULL
.	NULL

This	NULL
assay	NULL
assesses	NULL
the	NULL
extent	NULL
of	NULL
interaction	NULL
among	NULL
different	NULL
yeast	NULL
clones	NULL
where	NULL
individual	NULL
clones	NULL
have	NULL
different	NULL
numbers	NULL
of	NULL
copies	NULL
of	NULL
the	NULL
two	NULL
expression	NULL
vectors	NULL
.	NULL

B-Galactosidase	NULL
production	NULL
was	NULL
monitored	NULL
by	NULL
assessing	NULL
the	NULL
chronology	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

and	NULL
intensity	NULL
of	NULL
color	NULL
development	NULL
over	NULL
20	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

TRAF3	NULL
interacted	NULL
strongly	NULL
with	NULL
wild-type	NULL
LMP1	NULL
amino	NULL
acids	NULL
182	NULL
to	NULL
386	NULL
or	NULL
with	NULL
ID-mutated	NULL
LMP1	NULL
.	NULL

Most	NULL
doubly	NULL
transfected	NULL
yeast	NULL
clones	NULL
were	NULL
blue	NULL
by	NULL
2	NULL
h	NULL
and	NULL
dark	NULL
blue	NULL
by	NULL
4	NULL
h.	NULL
TRADD	NULL
and	NULL
RIP	NULL
interacted	NULL
with	NULL
LMP1	NULL
at	NULL
substantially	NULL
lower	NULL
levels	NULL
,	NULL
with	NULL
blue	NULL
to	NULL
dark	NULL
blue	NULL
coloration	NULL
developing	NULL
in	NULL
only	NULL
19	NULL
%	NULL
of	NULL
the	NULL
TRADD	NULL
clones	NULL
and	NULL
7	NULL
%	NULL
of	NULL
the	NULL
RIP	NULL
clones	NULL
by	NULL
20	NULL
h.	NULL
Dark	NULL
blue	NULL
coloration	NULL
was	NULL
unusual	NULL
even	NULL
at	NULL
20	NULL
h.	NULL
A	NULL
similar	NULL
hierarchy	NULL
of	NULL
slightly	NULL
stronger	NULL
TRADD	NULL
than	NULL
RIP	NULL
interaction	NULL
was	NULL
evident	NULL
in	NULL
light	NULL
blue	NULL
coloration	NULL
at	NULL
2	NULL
h	NULL
,	NULL
with	NULL
12	NULL
%	NULL
for	NULL
TRADD	NULL
and	NULL
none	NULL
for	NULL
RIP	NULL
.	NULL

1007	NULL
2hours	NULL
4	NULL
hours	NULL
20	NULL
hours	NULL
CD	NULL
LL	NULL
&	NULL
80	NULL
’	NULL
_	NULL
£	NULL
s	NULL
60-©	NULL
2	NULL
&	NULL
40	NULL
eM	NULL
T	NULL
?	NULL

20-ca	NULL
®	NULL
0	NULL
WT	NULL
-	NULL
ID	NULL
WT	NULL
-	NULL
ID	NULL
WT	NULL
-	NULL
ID	NULL
2	NULL
hours	NULL
4	NULL
hours	NULL
20	NULL
hours	NULL
100	NULL
A	NULL
1	NULL
o	NULL
&	NULL
so-F—	NULL
£	NULL
s	NULL
604	NULL
0	NULL
2	NULL
7	NULL
§	NULL
404	NULL
a	NULL
T	NULL
7	NULL
20-ca	NULL
.	NULL

§	NULL
JA	NULL
=d	NULL
WT	NULL
-	NULL
dD	NULL
WT	NULL
-	NULL
ID	NULL
WT	NULL
-	NULL
ID	NULL
2	NULL
hours	NULL
4	NULL
hours	NULL
20	NULL
hours	NULL
100	NULL
a	NULL
.	NULL

[	NULL
a	NULL
807	NULL
5	NULL
,	NULL
s	NULL
o	NULL
607	NULL
2	NULL
f	NULL
3	NULL
407	NULL
o	NULL
J	NULL
a	NULL
.	NULL

204	NULL
e	NULL
o	NULL
[	NULL
]	NULL
WT	NULL
_	NULL
1D	NULL
WT	NULL
-	NULL
ID	NULL
WT	NULL
-	NULL
ID	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Yeast	NULL
two-hybrid	NULL
assay	NULL
of	NULL
LMP1	NULL
interaction	NULL
with	NULL
TRAF3	NULL
,	NULL
TRADD	NULL
,	NULL
or	NULL
RIP	NULL
monitored	NULL
by	NULL
B-galactosidase	NULL
conversion	NULL
of	NULL
X-Gal	NULL
.	NULL

S.	NULL
cerevisiae	NULL
Y¥190	NULL
was	NULL
transformed	NULL
with	NULL
pAS1	NULL
vectors	NULL
expressing	NULL
the	NULL
Gal4	NULL
DBD	NULL
fused	NULL
to	NULL
LMP1	NULL
amino	NULL
acids	NULL
187	NULL
to	NULL
386	NULL
(	NULL
wild	NULL
type	NULL
[	NULL
WT	NULL
]	NULL
)	NULL
or	NULL
fused	NULL
to	NULL
LMP1	NULL
amino	NULL
acids	NULL
187	NULL
to	NULL
386	NULL
with	NULL
a	NULL
mutation	NULL
of	NULL
Y35	NULL
,	NULL
YD	NULL
;	NULL
84	NULL
to	NULL
ID	NULL
(	NULL
ID	NULL
)	NULL
and	NULL
with	NULL
pACT2	NULL
vectors	NULL
expressing	NULL
the	NULL
Gal4	NULL
AD	NULL
fused	NULL
to	NULL
TRAF3	NULL
(	NULL
residues	NULL
312	NULL
to	NULL
568	NULL
)	NULL
,	NULL
TRADD	NULL
(	NULL
residues	NULL
1	NULL
to	NULL
312	NULL
)	NULL
,	NULL
or	NULL
RIP	NULL
(	NULL
residues	NULL
1	NULL
to	NULL
671	NULL
)	NULL
.	NULL

Cotransformed	NULL
yeast	NULL
cells	NULL
were	NULL
selected	NULL
on	NULL
medium	NULL
deficient	NULL
in	NULL
tryptophan	NULL
and	NULL
leucine	NULL
;	NULL
32	NULL
colonies	NULL
were	NULL
individually	NULL
transferred	NULL
to	NULL
filters	NULL
,	NULL
frozen	NULL
,	NULL
and	NULL
thawed	NULL
twice	NULL
,	NULL
incubated	NULL
at	NULL
37°C	NULL
with	NULL
1	NULL
mg	NULL
of	NULL
X-Gal	NULL
per	NULL
ml	NULL
in	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
sodium	NULL
phosphate	NULL
[	NULL
pH	NULL
7.0	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.13	NULL
mM	NULL
2-mercapto-ethanol	NULL
)	NULL
,	NULL
and	NULL
monitored	NULL
for	NULL
blue-colored	NULL
product	NULL
.	NULL

Intensity	NULL
was	NULL
scored	NULL
as	NULL
dark	NULL
blue	NULL
(	NULL
@	NULL
I	NULL
,	NULL
blue	NULL
(	NULL
&	NULL
)	NULL
,	NULL
or	NULL
light	NULL
blue	NULL
(	NULL
0	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
Input	NULL
Unbound	NULL
Imm	NULL
Ppt	NULL
rie	NULL
&	NULL
_	NULL
200	NULL
§	NULL
1	NULL
%	NULL
0	NULL
10	NULL
$	NULL
LL	NULL
-I	NULL
LL	NULL
-I	NULL
LL	NULL
-I	NULL
40.05	NULL
.60	NULL
.12	NULL
.40	NULL
.60	NULL
13	NULL
20	NULL
%	NULL
RIP	NULL
ee	NULL
-=	NULL
|	NULL
,	NULL
Thao	NULL
qa	NULL
aer	NULL
an	NULL
oy	NULL
wad	NULL
LMP1	NULL
-	NULL
``	NULL
--	NULL
``	NULL
``	NULL
y	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Coimmunoprecipitation	NULL
of	NULL
RIP	NULL
or	NULL
TRADD	NULL
with	NULL
F-LMP1	NULL
.	NULL

Proteins	NULL
from	NULL
LCLs	NULL
(	NULL
2.0	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
infected	NULL
with	NULL
an	NULL
EBV	NULL
recombinant	NULL
expressing	NULL
F-LMP1	NULL
or	NULL
wild-type	NULL
LMP1	NULL
were	NULL
solubilized	NULL
by	NULL
Dounce	NULL
disruption	NULL
in	NULL
0.5	NULL
%	NULL
Brij	NULL
58-100	NULL
mM	NULL
NaCl-50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
Flag-specific	NULL
M2	NULL
affinity	NULL
gel	NULL
(	NULL
Kodak	NULL
)	NULL
.	NULL

Precipitated	NULL
proteins	NULL
were	NULL
Western	NULL
blotted	NULL
with	NULL
antisera	NULL
to	NULL
RIP	NULL
(	NULL
Pharmingen	NULL
)	NULL
,	NULL
TRADD	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
or	NULL
S12	NULL
monoclonal	NULL
antibody	NULL
to	NULL
LMP1	NULL
.	NULL

Input	NULL
lanes	NULL
represent	NULL
unfractionated	NULL
cell	NULL
pro-teins	NULL
,	NULL
unbound	NULL
lanes	NULL
represent	NULL
proteins	NULL
not	NULL
precipitated	NULL
with	NULL
M2	NULL
affinity	NULL
gel	NULL
,	NULL
and	NULL
Imm	NULL
Ppt	NULL
lanes	NULL
represent	NULL
immunoprecipitated	NULL
proteins	NULL
.	NULL

Percentages	NULL
indicate	NULL
fractions	NULL
of	NULL
total	NULL
samples	NULL
analyzed	NULL
.	NULL

Both	NULL
TRADD	NULL
and	NULL
RIP	NULL
interacted	NULL
better	NULL
with	NULL
wild-type	NULL
LMP1	NULL
than	NULL
with	NULL
the	NULL
ID	NULL
mutant	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
TES1/CTAR1	NULL
interaction	NULL
with	NULL
TRAF3	NULL
is	NULL
considerably	NULL
stronger	NULL
than	NULL
TES2/CTAR2	NULL
interaction	NULL
with	NULL
TRADD	NULL
,	NULL
and	NULL
interaction	NULL
with	NULL
TRADD	NULL
is	NULL
stronger	NULL
than	NULL
interaction	NULL
with	NULL
RIP	NULL
.	NULL

RIP	NULL
is	NULL
associated	NULL
with	NULL
LMP1	NULL
in	NULL
an	NULL
EBV-transformed	NULL
LCL	NULL
.	NULL

RIP	NULL
association	NULL
with	NULL
LMP1	NULL
was	NULL
evaluated	NULL
in	NULL
an	NULL
LCL	NULL
transformed	NULL
by	NULL
an	NULL
EBV	NULL
recombinant	NULL
that	NULL
expresses	NULL
F-LMP1I	NULL
.	NULL

F-LMP1	NULL
was	NULL
precipitated	NULL
with	NULL
antibody	NULL
M2	NULL
,	NULL
and	NULL
coimmunopre-cipitated	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Another	NULL
LCL	NULL
transformed	NULL
in	NULL
parallel	NULL
by	NULL
a	NULL
wild-type	NULL
EBV	NULL
that	NULL
has	NULL
an	NULL
LMP1	NULL
gene	NULL
without	NULL
a	NULL
Flag	NULL
epitope	NULL
served	NULL
as	NULL
a	NULL
specificity	NULL
control	NULL
for	NULL
the	NULL
immunoprecipitation	NULL
.	NULL

RIP	NULL
,	NULL
TRADD	NULL
,	NULL
and	NULL
LMP1	NULL
levels	NULL
were	NULL
similar	NULL
in	NULL
the	NULL
input	NULL
lysates	NULL
from	NULL
the	NULL
two	NULL
LCLs	NULL
.	NULL

F-LMP1	NULL
was	NULL
highly	NULL
enriched	NULL
in	NULL
the	NULL
Flag	NULL
antibody	NULL
immunoprecipitate	NULL
,	NULL
whereas	NULL
only	NULL
a	NULL
trace	NULL
of	NULL
LMP1	NULL
was	NULL
nonspecifically	NULL
immunoprecipitated	NULL
by	NULL
the	NULL
Flag	NULL
antibody	NULL
.	NULL

After	NULL
correction	NULL
for	NULL
the	NULL
efficiency	NULL
of	NULL
F-LMP1	NULL
precipitation	NULL
,	NULL
approximately	NULL
8	NULL
%	NULL
of	NULL
TRADD	NULL
and	NULL
4	NULL
%	NULL
of	NULL
RIP	NULL
were	NULL
stably	NULL
associated	NULL
with	NULL
F-LMP1	NULL
.	NULL

Neither	NULL
TRADD	NULL
nor	NULL
RIP	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
Flag	NULL
antibody	NULL
control	NULL
immunoprecipitate	NULL
from	NULL
the	NULL
cell	NULL
line	NULL
transformed	NULL
with	NULL
wild-type	NULL
EBV	NULL
.	NULL

RIP	NULL
overexpression	NULL
has	NULL
an	NULL
additive	NULL
effect	NULL
on	NULL
LMP1-medi-ated	NULL
NF-KB	NULL
activation	NULL
.	NULL

HEK293	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
LMP1	NULL
TES2/CTAR2	NULL
vector	NULL
(	NULL
wild-type	NULL
F-LMP1A	NULL
or	NULL
mutated	NULL
F-LMP1AID	NULL
)	NULL
,	NULL
a	NULL
TRADD	NULL
or	NULL
RIP	NULL
vector	NULL
,	NULL
and	NULL
a	NULL
luciferase	NULL
reporter	NULL
with	NULL
three	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
lower	NULL
level	NULL
of	NULL
interaction	NULL
with	NULL
LMP1	NULL
in	NULL
yeast	NULL
and	NULL
the	NULL
lower	NULL
level	NULL
of	NULL
association	NULL
in	NULL
LCLs	NULL
,	NULL
RIP	NULL
did	NULL
not	NULL
synergize	NULL
with	NULL
LMP1	NULL
TES2/	NULL
CTAR2	NULL
in	NULL
NF-kB	NULL
activation	NULL
.	NULL

While	NULL
LMP1	NULL
TES2/CTAR2	NULL
activated	NULL
NF-kB	NULL
about	NULL
12-fold	NULL
and	NULL
RIP	NULL
overexpression	NULL
resulted	NULL
in	NULL
7-fold	NULL
NF-kB	NULL
activation	NULL
,	NULL
cotransfection	NULL
of	NULL
LMP1	NULL
TES2/	NULL
CTAR2	NULL
with	NULL
RIP	NULL
resulted	NULL
in	NULL
24-fold	NULL
activation	NULL
,	NULL
marginally	NULL
better	NULL
than	NULL
the	NULL
19-fold	NULL
expected	NULL
from	NULL
a	NULL
simple	NULL
additive	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
TRADD	NULL
activated	NULL
10-fold	NULL
and	NULL
LMP1	NULL
TES2/CTAR2	NULL
cotransfected	NULL
with	NULL
TRADD	NULL
activated	NULL
44-fold	NULL
,	NULL
substantially	NULL
more	NULL
than	NULL
the	NULL
22-fold	NULL
expected	NULL
from	NULL
an	NULL
additive	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

ID-mutated	NULL
LMP1	NULL
TES2/CTAR2	NULL
activated	NULL
NF-kB	NULL
similarly	NULL
to	NULL
vector	NULL
alone	NULL
,	NULL
and	NULL
cotransfection	NULL
of	NULL
ID-mutated	NULL
LMP1	NULL
TES2/CTAR2	NULL
with	NULL
RIP	NULL
activated	NULL
NF-kB	NULL
12-fold	NULL
,	NULL
marginally	NULL
better	NULL
than	NULL
the	NULL
eightfold	NULL
expected	NULL
from	NULL
an	NULL
LMP1	NULL
SIGNALS	NULL
TRANSFORMATION	NULL
THROUGH	NULL
TRADD	NULL
AND	NULL
RIP	NULL
-	NULL
5763	NULL
additive	NULL
effect	NULL
.	NULL

Similarly	NULL
,	NULL
ID-mutated	NULL
LMP1	NULL
TES2/CTAR2	NULL
and	NULL
TRADD	NULL
cotransfection	NULL
activated	NULL
NF-kB	NULL
18-fold	NULL
,	NULL
marginally	NULL
better	NULL
than	NULL
the	NULL
11-fold	NULL
expected	NULL
from	NULL
an	NULL
additive	NULL
effect	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
while	NULL
TRADD	NULL
synergizes	NULL
with	NULL
LMP1	NULL
TES/CTAR2	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
RIP	NULL
has	NULL
only	NULL
slightly	NULL
more	NULL
than	NULL
an	NULL
additive	NULL
effect	NULL
on	NULL
LMP1	NULL
TES2/CTAR2-mediated	NULL
NF-kB	NULL
activation	NULL
.	NULL

RIP	NULL
is	NULL
critical	NULL
for	NULL
TNFR1	NULL
but	NULL
less	NULL
critical	NULL
for	NULL
TES2/CTAR2-mediated	NULL
NF-KB	NULL
activation	NULL
.	NULL

Selection	NULL
of	NULL
mutagenized	NULL
Jurkat	NULL
(	NULL
SVT35	NULL
)	NULL
T-lymphoma	NULL
cells	NULL
for	NULL
mutants	NULL
deficient	NULL
in	NULL
TNFR1-mediated	NULL
NF-KB	NULL
activation	NULL
yielded	NULL
a	NULL
clone	NULL
(	NULL
35.3.13	NULL
)	NULL
that	NULL
lacks	NULL
RIP	NULL
expression	NULL
and	NULL
in	NULL
which	NULL
TNFR1-mediated	NULL
NF-kB	NULL
activation	NULL
can	NULL
be	NULL
restored	NULL
by	NULL
transfection	NULL
with	NULL
a	NULL
RIP	NULL
expression	NULL
vector	NULL
(	NULL
54	NULL
)	NULL
.	NULL

These	NULL
results	NULL
point	NULL
to	NULL
a	NULL
critical	NULL
RIP	NULL
function	NULL
in	NULL
TNFR1-mediated	NULL
NF-kB	NULL
activation	NULL
.	NULL

Since	NULL
TRADD	NULL
is	NULL
the	NULL
proximal	NULL
mediator	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
from	NULL
both	NULL
TNFR1	NULL
and	NULL
TES2/CTAR2	NULL
,	NULL
RIP	NULL
might	NULL
be	NULL
expected	NULL
to	NULL
be	NULL
an	NULL
effector	NULL
of	NULL
LMP1	NULL
TES2/CTAR2-mediated	NULL
Surprisingly	NULL
,	NULL
transfection	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
TES2/CTAR2	NULL
vector	NULL
F-LMP1IA	NULL
into	NULL
SVT35	NULL
or	NULL
35.3.13	NULL
cells	NULL
resulted	NULL
in	NULL
similar	NULL
levels	NULL
and	NULL
parallel	NULL
increases	NULL
in	NULL
NF-KB	NULL
activation	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

F-LMP1	NULL
(	NULL
both	NULL
TES1/CTAR1	NULL
and	NULL
TES2/CTAR2	NULL
)	NULL
was	NULL
slightly	NULL
more	NULL
active	NULL
overall	NULL
than	NULL
F-LMP1A	NULL
but	NULL
also	NULL
was	NULL
not	NULL
different	NULL
in	NULL
NF-kB	NULL
activation	NULL
in	NULL
SVT35	NULL
or	NULL
35.3.13	NULL
cells	NULL
.	NULL

The	NULL
35.3.13	NULL
cells	NULL
were	NULL
confirmed	NULL
to	NULL
lack	NULL
RIP	NULL
and	NULL
for	NULL
TNF-	NULL
«	NULL
to	NULL
be	NULL
unable	NULL
to	NULL
activate	NULL
NF-kB	NULL
,	NULL
whereas	NULL
SVT35	NULL
cells	NULL
were	NULL
confirmed	NULL
to	NULL
express	NULL
RIP	NULL
and	NULL
for	NULL
TNF-a	NULL
to	NULL
activate	NULL
NF-kB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
RIP	NULL
is	NULL
not	NULL
an	NULL
obligate	NULL
intermediary	NULL
for	NULL
LMP1	NULL
TES2/	NULL
CTAR-mediated	NULL
activation	NULL
through	NULL
TRADD	NULL
.	NULL

LMP1	NULL
TES2/CTAR2	NULL
does	NULL
not	NULL
induce	NULL
apoptosis	NULL
in	NULL
BJAB	NULL
B-lymphoma	NULL
or	NULL
HEK293	NULL
cell	NULL
lines	NULL
,	NULL
while	NULL
TRADD	NULL
induces	NULL
apoptosis	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

TNF-	NULL
«	NULL
induces	NULL
TNFR1	NULL
to	NULL
recruit	NULL
TRADD	NULL
and	NULL
then	NULL
FADD	NULL
,	NULL
which	NULL
mediates	NULL
caspase	NULL
8	NULL
recruitment	NULL
and	NULL
initiation	NULL
of	NULL
apoptosis	NULL
signaling	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
1	NULL
)	NULL
.	NULL

LMP1	NULL
overexpression	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
RHEK	NULL
cells	NULL
(	NULL
37	NULL
)	NULL
and	NULL
to	NULL
be	NULL
toxic	NULL
in	NULL
BALB/c	NULL
3T3	NULL
,	NULL
HEp-2	NULL
,	NULL
143/EBNA1	NULL
,	NULL
and	NULL
B-lymphoblast	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
,	NULL
based	NULL
on	NULL
a	NULL
50	NULL
pe	NULL
1	NULL
$	NULL
40-LL	NULL
]	NULL
A	NULL
T	NULL
|	NULL
£	NULL
E	NULL
30_	NULL
G	NULL
_	NULL
2	NULL
g	NULL
0320	NULL
;	NULL
20	NULL
]	NULL
u	NULL
.	NULL

1	NULL
Z	NULL
J	NULL
g	NULL
107	NULL
+	NULL
Ll-	NULL
OA|—|	NULL
lil	NULL
ES	NULL
2d	NULL
se	NULL
)	NULL
o	NULL
c.	NULL
C	NULL
[	NULL
en	NULL
(	NULL
al	NULL
C2	NULL
Q	NULL
c.	NULL
&	NULL
-C	NULL
&	NULL
0	NULL
2	NULL
&	NULL
.	NULL

s	NULL
Q	NULL
@	NULL
c	NULL
3	NULL
Q	NULL
c	NULL
3	NULL
Q9	NULL
F	NULL
a	NULL
C	NULL
q	NULL
q	NULL
€	NULL
a	NULL
I-	NULL
a	NULL
-	NULL
a	NULL
I-pSGS5	NULL
FE-LMP1A	NULL
F-LMP1A	NULL
ID	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

TRADD	NULL
but	NULL
not	NULL
RIP	NULL
synergistically	NULL
activates	NULL
NF-kB	NULL
with	NULL
LMP1	NULL
.	NULL

Five	NULL
million	NULL
HEK293	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
TES2/CTAR2	NULL
vector	NULL
F-LMP1A	NULL
,	NULL
or	NULL
6	NULL
pg	NULL
of	NULL
F-LMP1AID	NULL
vector	NULL
3	NULL
ug	NULL
of	NULL
TRADD	NULL
vector	NULL
or	NULL
0.35	NULL
g	NULL
of	NULL
RIP	NULL
vector	NULL
,	NULL
and	NULL
the	NULL
NF-kB	NULL
and	NULL
B-galactosidase	NULL
reporters	NULL
used	NULL
for	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

Results	NULL
were	NULL
analyzed	NULL
as	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

5764	NULL
IZUMI	NULL
ET	NULL
AL	NULL
.	NULL

RIP	NULL
+	NULL
RIP	NULL
-	NULL
RIP	NULL
+	NULL
RIP	NULL
SVT35	NULL
35.3.13	NULL
SVT35	NULL
35.3.13	NULL
5	NULL
1	NULL
§	NULL
-	NULL
]	NULL
E	NULL
_	NULL
[	NULL
+	NULL
]	NULL
40	NULL
§	NULL
G	NULL
r	NULL
s	NULL
1	NULL
S	NULL
ao	NULL
1	NULL
€	NULL
30	NULL
6	NULL
A	NULL
c	NULL
B	NULL
0	NULL
4	NULL
g	NULL
207T	NULL
--	NULL
=	NULL
6	NULL
_	NULL
<	NULL
_	NULL
€	NULL
B	NULL
#	NULL
0497	NULL
|	NULL
Z	NULL
[	NULL
°\°	NULL
A	NULL
o-ug	NULL
DNA	NULL
1	NULL
3	NULL
9	NULL
1	NULL
3	NULL
9	NULL
1	NULL
3	NULL
9	NULL
1	NULL
3	NULL
9	NULL
F-L.MP1	NULL
F-LMP1A	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

LMP1	NULL
or	NULL
LMP1	NULL
TES2/CTAR2	NULL
deleted	NULL
for	NULL
residues	NULL
187	NULL
to	NULL
351	NULL
activates	NULL
NF-kB	NULL
in	NULL
RIP-positive	NULL
SVT35	NULL
Jurkat	NULL
cells	NULL
and	NULL
RIP-deficient	NULL
35.3.13	NULL
Jurkat	NULL
cells	NULL
.	NULL

Fifteen	NULL
million	NULL
SVT3S	NULL
or	NULL
35.3.13	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
9	NULL
ug	NULL
of	NULL
pSGS5	NULL
or	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
F-LMP1	NULL
vector	NULL
or	NULL
TES2/CTAR2	NULL
vector	NULL
F-LMP1A	NULL
and	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
3x-	NULL
«	NULL
B-L	NULL
,	NULL
an	NULL
NF-	NULL
«	NULL
B-responsive	NULL
luciferase	NULL
reporter	NULL
.	NULL

After	NULL
18	NULL
h	NULL
,	NULL
cultures	NULL
were	NULL
divided	NULL
in	NULL
two	NULL
.	NULL

One-half	NULL
was	NULL
untreated	NULL
,	NULL
while	NULL
the	NULL
other	NULL
half	NULL
was	NULL
stimulated	NULL
with	NULL
200	NULL
nM	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
10	NULL
nM	NULL
ionomycin	NULL
for	NULL
4	NULL
h	NULL
,	NULL
at	NULL
which	NULL
time	NULL
both	NULL
samples	NULL
were	NULL
tested	NULL
and	NULL
compared	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
are	NULL
the	NULL
means	NULL
of	NULL
relative	NULL
light	NULL
unit	NULL
(	NULL
RLU	NULL
)	NULL
emission	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
LMP1	NULL
vector	NULL
divided	NULL
by	NULL
the	NULL
RLU	NULL
emission	NULL
of	NULL
cells	NULL
further	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
minus	NULL
baseline	NULL
values	NULL
for	NULL
pSG5	NULL
vector-transfected	NULL
cultures	NULL
.	NULL

In	NULL
SVT35	NULL
(	NULL
RIP-positive	NULL
)	NULL
cells	NULL
,	NULL
unstimulated	NULL
and	NULL
maximally	NULL
activated	NULL
luciferase	NULL
activities	NULL
were	NULL
2,800	NULL
and	NULL
109,000	NULL
RLU	NULL
,	NULL
respectively	NULL
(	NULL
baseline	NULL
2.6	NULL
%	NULL
of	NULL
maximum	NULL
)	NULL
,	NULL
whereas	NULL
in	NULL
35.3.13	NULL
(	NULL
RIP-negative	NULL
)	NULL
cells	NULL
,	NULL
unstimulated	NULL
and	NULL
maximally	NULL
activated	NULL
luciferase	NULL
activities	NULL
were	NULL
7,800	NULL
and	NULL
111,000	NULL
RLU	NULL
,	NULL
respectively	NULL
(	NULL
baseline	NULL
7.1	NULL
%	NULL
of	NULL
maximum	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
F-LMP1	NULL
and	NULL
F-LMP1A	NULL
were	NULL
monitored	NULL
by	NULL
Western	NULL
immunoblotting	NULL
and	NULL
were	NULL
equivalent	NULL
at	NULL
the	NULL
same	NULL
DNA	NULL
dosage	NULL
for	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

Further	NULL
,	NULL
RIP	NULL
expression	NULL
in	NULL
SVT35	NULL
and	NULL
deficiency	NULL
in	NULL
35.3.13	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
immunoblotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

lower	NULL
yield	NULL
of	NULL
stable	NULL
cell	NULL
lines	NULL
with	NULL
LMP1	NULL
expression	NULL
vector	NULL
versus	NULL
controls	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
these	NULL
effects	NULL
are	NULL
due	NULL
to	NULL
TRADD-mediated	NULL
apoptosis	NULL
,	NULL
BJAB	NULL
B-lymphoma	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
a	NULL
GFP	NULL
expression	NULL
vector	NULL
and	NULL
either	NULL
TRADD	NULL
,	NULL
LMP1	NULL
TES2/CTAR2	NULL
,	NULL
ID-mutated	NULL
LMP1	NULL
TES2/CTAR2	NULL
,	NULL
or	NULL
pSGS	NULL
vector	NULL
.	NULL

One	NULL
hour	NULL
after	NULL
transfection	NULL
,	NULL
live	NULL
cells	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
on	NULL
a	NULL
Ficoll-Hypaque	NULL
step	NULL
gradient	NULL
and	NULL
cultured	NULL
for	NULL
10	NULL
h.	NULL
Each	NULL
culture	NULL
was	NULL
then	NULL
divided	NULL
in	NULL
two	NULL
;	NULL
one-half	NULL
was	NULL
treated	NULL
with	NULL
cycloheximide	NULL
to	NULL
enhance	NULL
apoptosis	NULL
,	NULL
and	NULL
the	NULL
other	NULL
half	NULL
was	NULL
untreated	NULL
.	NULL

Eight	NULL
hours	NULL
later	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
fixed	NULL
,	NULL
DNA	NULL
was	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
,	NULL
and	NULL
the	NULL
frequency	NULL
of	NULL
hypodiploid	NULL
transfected	NULL
cells	NULL
was	NULL
assessed	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

Approximately	NULL
50	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
GFP	NULL
positive	NULL
,	NULL
and	NULL
LMP1	NULL
TES2/CTAR2	NULL
expression	NULL
did	NULL
not	NULL
affect	NULL
GFP	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

LMP1	NULL
TES2/CTAR2	NULL
and	NULL
ID-mutated	NULL
TES2/CTAR2	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
as	NULL
assessed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
hypodiploid	NULL
cells	NULL
were	NULL
between	NULL
8	NULL
and	NULL
13	NULL
%	NULL
in	NULL
LMP1	NULL
TES2/CTAR2	NULL
,	NULL
ID-mutated	NULL
LMP1	NULL
TES2/CTAR2	NULL
,	NULL
or	NULL
pSGS	NULL
vector-transfected	NULL
cells	NULL
,	NULL
while	NULL
TRADD	NULL
induced	NULL
apoptosis	NULL
in	NULL
45	NULL
%	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Cycloheximide	NULL
treatment	NULL
very	NULL
slightly	NULL
increased	NULL
apoptosis	NULL
in	NULL
LMP1	NULL
TES2/	NULL
CTAR2	NULL
,	NULL
ID-mutated	NULL
LMP1	NULL
TES2/CTAR2	NULL
,	NULL
or	NULL
pSGS5	NULL
vector-transfected	NULL
cells	NULL
,	NULL
while	NULL
TRADD-mediated	NULL
apoptosis	NULL
was	NULL
substantially	NULL
enhanced	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
TES2/CTAR2	NULL
does	NULL
not	NULL
activate	NULL
apoptosis	NULL
in	NULL
BJAB	NULL
B	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

lymphoma	NULL
cells	NULL
despite	NULL
the	NULL
ability	NULL
to	NULL
engage	NULL
and	NULL
constitutively	NULL
associate	NULL
with	NULL
TRADD	NULL
and	NULL
RIP	NULL
.	NULL

Since	NULL
BJAB	NULL
cells	NULL
have	NULL
a	NULL
high	NULL
constitutive	NULL
level	NULL
of	NULL
activated	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
have	NULL
antiapoptotic	NULL
effects	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
LMP1	NULL
could	NULL
cause	NULL
apoptosis	NULL
in	NULL
cells	NULL
that	NULL
have	NULL
low	NULL
basal	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

We	NULL
chose	NULL
HEK293	NULL
cells	NULL
since	NULL
they	NULL
are	NULL
used	NULL
to	NULL
demonstrate	NULL
TRADD-mediated	NULL
apoptosis	NULL
(	NULL
22	NULL
)	NULL
and	NULL
switched	NULL
to	NULL
peDNA3	NULL
as	NULL
the	NULL
vector	NULL
for	NULL
expression	NULL
of	NULL
LMP1	NULL
or	NULL
LMP1	NULL
TES2/CTAR2	NULL
because	NULL
of	NULL
the	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
in	NULL
HEK293	NULL
cells	NULL
.	NULL

The	NULL
constitutively	NULL
expressed	NULL
reporter	NULL
pGK-B-galactosidase	NULL
was	NULL
used	NULL
as	NULL
a	NULL
marker	NULL
for	NULL
transfected	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
type	NULL
of	NULL
assay	NULL
,	NULL
apoptotic	NULL
cells	NULL
exhibit	NULL
characteristic	NULL
changes	NULL
in	NULL
cell	NULL
morphology	NULL
(	NULL
rounding	NULL
up	NULL
)	NULL
or	NULL
detach	NULL
from	NULL
the	NULL
substratum	NULL
.	NULL

Transfection	NULL
with	NULL
LMP1	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
,	NULL
panel	NULL
3	NULL
)	NULL
or	NULL
LMP1	NULL
CTAR2/TES2	NULL
(	NULL
panel	NULL
5	NULL
)	NULL
expression	NULL
vectors	NULL
did	NULL
not	NULL
markedly	NULL
increase	NULL
the	NULL
percentage	NULL
of	NULL
B-galactosidase-positive	NULL
cells	NULL
scored	NULL
as	NULL
apoptotic	NULL
compared	NULL
with	NULL
vector-transfected	NULL
cells	NULL
(	NULL
panel	NULL
1	NULL
)	NULL
.	NULL

TRADD	NULL
vector	NULL
transfection	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
substantially	NULL
increased	NULL
the	NULL
percentage	NULL
of	NULL
B-galac-tosidase-positive	NULL
,	NULL
apoptotic	NULL
cells	NULL
to	NULL
57	NULL
%	NULL
(	NULL
panel	NULL
2	NULL
)	NULL
.	NULL

To	NULL
eliminate	NULL
the	NULL
possibility	NULL
that	NULL
LMP1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
protecting	NULL
the	NULL
cells	NULL
from	NULL
LMP1	NULL
TES2/CTAR2-TRADD-mediated	NULL
apoptosis	NULL
,	NULL
a	NULL
nondegradable	NULL
form	NULL
of	NULL
IxBa	NULL
with	NULL
alanine	NULL
substitutions	NULL
for	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
(	NULL
IxBa	NULL
SSAA	NULL
[	NULL
6	NULL
]	NULL
)	NULL
was	NULL
coexpressed	NULL
with	NULL
an	NULL
LMP1	NULL
or	NULL
LMP1	NULL
TES2/CTAR2	NULL
vector	NULL
.	NULL

Cells	NULL
were	NULL
also	NULL
cotransfected	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B-responsive	NULL
luciferase	NULL
reporter	NULL
to	NULL
monitor	NULL
the	NULL
effect	NULL
of	NULL
IxBa	NULL
SSAA	NULL
on	NULL
NF-kB	NULL
activation	NULL
.	NULL

NF-kB	NULL
activation	NULL
by	NULL
LMP1	NULL
TES2/CTAR2	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
the	NULL
coexpression	NULL
of	NULL
IxBa	NULL
SSAA	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
apoptosis	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
either	NULL
LMP1-or	NULL
LMP1	NULL
TES2/CTAR2-expressing	NULL
cells	NULL
even	NULL
with	NULL
IxBa	NULL
SSAA	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
,	NULL
panels	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

IxBa	NULL
SSAA	NULL
expression	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
LMP1	NULL
or	NULL
LMP1	NULL
TES2/CTAR2	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
demonstrate	NULL
that	NULL
LMP1	NULL
TES2/	NULL
F-LMP1	NULL
AID	NULL
TRADD	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

F-LMP1A	NULL
and	NULL
F-LMP1AID	NULL
do	NULL
not	NULL
activate	NULL
programmed	NULL
cell	NULL
death	NULL
,	NULL
whereas	NULL
TRADD	NULL
induces	NULL
apoptosis	NULL
.	NULL

BJAB	NULL
B-lymphoma	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
GFP	NULL
vector	NULL
pEGFP	NULL
(	NULL
Clontech	NULL
)	NULL
and	NULL
with	NULL
pSG5	NULL
,	NULL
TES2/CTAR2	NULL
vector	NULL
F-LMP1A	NULL
,	NULL
F-LMP1AID	NULL
vector	NULL
,	NULL
or	NULL
TRADD	NULL
vector	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
dead	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Viable	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
10	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
cycloheximide	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

Next	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
paraformaldehyde	NULL
,	NULL
permeabilized	NULL
with	NULL
ethanol	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
DNA	NULL
with	NULL
propidium	NULL
iodide	NULL
.	NULL

DNA	NULL
content	NULL
in	NULL
GFP-positive	NULL
cells	NULL
was	NULL
quantitated	NULL
by	NULL
fluo-rescence-activated	NULL
cytometry	NULL
and	NULL
plotted	NULL
as	NULL
propidium	NULL
iodide	NULL
fluorescence	NULL
intensity	NULL
(	NULL
x	NULL
axis	NULL
)	NULL
versus	NULL
cell	NULL
frequency	NULL
(	NULL
y	NULL
axis	NULL
)	NULL
.	NULL

Apoptotic	NULL
cells	NULL
have	NULL
hypodiploid	NULL
DNA	NULL
content	NULL
(	NULL
A	NULL
,	NULL
,	NULL
)	NULL
and	NULL
are	NULL
indicated	NULL
by	NULL
a	NULL
line	NULL
at	NULL
the	NULL
left	NULL
and	NULL
percentage	NULL
at	NULL
the	NULL
right	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
for	NULL
cells	NULL
that	NULL
were	NULL
not	NULL
cycloheximide	NULL
treated	NULL
.	NULL

Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
\	NULL
.	NULL

sep	NULL
(	NULL
prat	NULL
:	NULL
.	NULL

LMP1	NULL
SIGNALS	NULL
TRANSFORMATION	NULL
THROUGH	NULL
TRADD	NULL
AND	NULL
RIP	NULL
_-	NULL
5765	NULL
B	NULL
o	NULL
O	NULL
)	NULL
§	NULL
20	NULL
Lo	NULL
TIC	NULL
.S	NULL
mn	NULL
¥	NULL
LL	NULL
Z	NULL
6	NULL
10	NULL
Fo	NULL
.2	NULL
Is	NULL
<	NULL
_J	NULL
O	NULL
LL	NULL
0	NULL
L	NULL
IcBa	NULL
SSAA	NULL
_-	NULL
-	NULL
+o	NULL
0	NULL
-	NULL
0	NULL
+	NULL
-	NULL
_	NULL
LMP1_	NULL
F-LMP1A	NULL
C	NULL
LMP	NULL
1	NULL
-	NULL
»	NULL
F-LMP1A-p-	NULL
<	NULL
=	NULL
%	NULL
__	NULL
TA	NULL
**	NULL
F-IxBa	NULL
SSAA-	NULL
#	NULL
P	NULL
IcBa	NULL
SSAA	NULL
_-	NULL
-o	NULL
f	NULL
-o	NULL
f	NULL
_	NULL
LMP1	NULL
_F-LMP1A	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

LMP1	NULL
and	NULL
F-LMP1A	NULL
do	NULL
not	NULL
activate	NULL
apoptosis	NULL
when	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
nondegradable	NULL
IxBa	NULL
(	NULL
IxBa	NULL
SSAA	NULL
)	NULL
.	NULL

HEK293	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
pcDNA3	NULL
(	NULL
panel	NULL
1	NULL
)	NULL
,	NULL
TRADD	NULL
(	NULL
panel	NULL
2	NULL
)	NULL
,	NULL
pcDNA3	NULL
LMP1	NULL
(	NULL
panel	NULL
3	NULL
)	NULL
,	NULL
peDNA3	NULL
LMP1	NULL
and	NULL
IxBa	NULL
SSAA	NULL
(	NULL
panel	NULL
4	NULL
)	NULL
,	NULL
TES2/CTAR2	NULL
vector	NULL
peDNA3	NULL
F-LMP1A	NULL
(	NULL
panel	NULL
5	NULL
)	NULL
,	NULL
or	NULL
pcDNA3	NULL
F-LMP1IA	NULL
and	NULL
IxBa	NULL
SSAA	NULL
(	NULL
panel	NULL
6	NULL
)	NULL
and	NULL
with	NULL
B-galactosidase	NULL
and	NULL
NF-kB	NULL
reporter	NULL
DNAs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cells	NULL
were	NULL
fixed	NULL
and	NULL
then	NULL
incubated	NULL
in	NULL
X-Gal	NULL
prior	NULL
to	NULL
photography	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
apoptotic	NULL
,	NULL
B-galactosidase-positive	NULL
cells	NULL
was	NULL
4	NULL
%	NULL
for	NULL
pecDNA3	NULL
(	NULL
panel	NULL
1	NULL
)	NULL
,	NULL
57	NULL
%	NULL
for	NULL
TRADD	NULL
(	NULL
panel	NULL
2	NULL
)	NULL
,	NULL
8	NULL
%	NULL
for	NULL
peDNA3	NULL
LMP1	NULL
(	NULL
panel	NULL
3	NULL
)	NULL
,	NULL
3	NULL
%	NULL
for	NULL
peDNA3	NULL
LMP1	NULL
and	NULL
IxBa	NULL
SSAA	NULL
(	NULL
panel	NULL
4	NULL
)	NULL
,	NULL
2	NULL
%	NULL
for	NULL
peDNA3	NULL
F-LMP1A	NULL
(	NULL
panel	NULL
5	NULL
)	NULL
,	NULL
and	NULL
3	NULL
%	NULL
for	NULL
peDNA3	NULL
F-LMP1A	NULL
and	NULL
IxBa	NULL
SSAA	NULL
(	NULL
panel	NULL
6	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NF-B	NULL
activation	NULL
as	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Western	NULL
immunoblot	NULL
assay	NULL
for	NULL
LMP1	NULL
and	NULL
IxBa	NULL
SSAA	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
size	NULL
separated	NULL
in	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
blotted	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
antibody	NULL
M2	NULL
(	NULL
Kodak	NULL
)	NULL
to	NULL
F-LMP1A	NULL
or	NULL
Flag-tagged	NULL
IxBa	NULL
SSAA	NULL
or	NULL
antibody	NULL
S12	NULL
to	NULL
F-LMP1	NULL
.	NULL

CTAR2	NULL
is	NULL
substantially	NULL
different	NULL
from	NULL
TNFR1	NULL
in	NULL
inducing	NULL
apoptosis	NULL
.	NULL

DISCUSSION	NULL
These	NULL
experiments	NULL
indicate	NULL
that	NULL
TES2/CTAR2	NULL
signaling	NULL
is	NULL
similar	NULL
but	NULL
not	NULL
identical	NULL
to	NULL
TNFR1	NULL
death	NULL
domain	NULL
signaling	NULL
.	NULL

TES2/CTAR2	NULL
and	NULL
TNFR1	NULL
directly	NULL
interact	NULL
with	NULL
the	NULL
TRADD	NULL
death	NULL
domain	NULL
and	NULL
stably	NULL
associate	NULL
with	NULL
TRADD	NULL
when	NULL
their	NULL
cytoplasmic	NULL
tails	NULL
are	NULL
aggregated	NULL
.	NULL

The	NULL
six	NULL
hydrophobic	NULL
transmembrane	NULL
domains	NULL
of	NULL
each	NULL
LMP1	NULL
molecule	NULL
mediate	NULL
constitutive	NULL
oligomeric	NULL
aggregation	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
whereas	NULL
trimeric	NULL
TNF-	NULL
«	NULL
ligand	NULL
mediates	NULL
trimerization	NULL
of	NULL
TNFR	NULL
1	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
20-22	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Both	NULL
LMP1	NULL
and	NULL
trimerized	NULL
TNFR1	NULL
associate	NULL
with	NULL
TRADD	NULL
,	NULL
recruit	NULL
TRAF	NULL
,	NULL
activate	NULL
NIK	NULL
and	NULL
IxB	NULL
kinases	NULL
,	NULL
phosphorylate	NULL
IxB	NULL
,	NULL
and	NULL
activate	NULL
NF-kB	NULL
(	NULL
1	NULL
,	NULL
11	NULL
,	NULL
28	NULL
,	NULL
38	NULL
,	NULL
39	NULL
,	NULL
46	NULL
,	NULL
52	NULL
,	NULL
58	NULL
,	NULL
59	NULL
)	NULL
.	NULL

LMP1	NULL
TES2/CTAR2	NULL
and	NULL
TNFR1	NULL
also	NULL
share	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
c-Jun	NULL
N-terminal	NULL
kinase/stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
JNK/SAPK	NULL
)	NULL
(	NULL
14	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
studies	NULL
reported	NULL
here	NULL
also	NULL
delineate	NULL
differences	NULL
between	NULL
LMP1	NULL
TES2/CTAR2	NULL
and	NULL
TNFR1	NULL
that	NULL
advance	NULL
our	NULL
understanding	NULL
of	NULL
how	NULL
LMP1	NULL
and	NULL
TNFR1	NULL
alter	NULL
cell	NULL
growth	NULL
and	NULL
survival	NULL
.	NULL

Eleven	NULL
amino	NULL
acids	NULL
of	NULL
LMP1	NULL
are	NULL
sufficient	NULL
for	NULL
engaging	NULL
the	NULL
TRADD	NULL
death	NULL
domain	NULL
to	NULL
activate	NULL
NF-kB	NULL
,	NULL
whereas	NULL
the	NULL
TNFR1	NULL
death	NULL
domain	NULL
that	NULL
engages	NULL
the	NULL
TRADD	NULL
death	NULL
domain	NULL
is	NULL
about	NULL
70	NULL
residues	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
while	NULL
TRADD	NULL
residues	NULL
296	NULL
to	NULL
299	NULL
or	NULL
300	NULL
to	NULL
302	NULL
are	NULL
critical	NULL
for	NULL
TRADD	NULL
interaction	NULL
with	NULL
itself	NULL
or	NULL
with	NULL
TNFR1	NULL
as	NULL
well	NULL
as	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
or	NULL
for	NULL
apoptosis	NULL
(	NULL
22	NULL
,	NULL
45	NULL
)	NULL
,	NULL
these	NULL
TRADD	NULL
residues	NULL
are	NULL
not	NULL
required	NULL
for	NULL
synergy	NULL
with	NULL
TES2/CTAR2	NULL
in	NULL
NF-kB	NULL
activation	NULL
.	NULL

A	NULL
mutant	NULL
TRADD	NULL
that	NULL
is	NULL
deleted	NULL
for	NULL
the	NULL
C-terminal	NULL
residues	NULL
294	NULL
to	NULL
312	NULL
and	NULL
for	NULL
most	NULL
of	NULL
the	NULL
N-terminal	NULL
TRAF	NULL
interaction	NULL
domain	NULL
even	NULL
had	NULL
a	NULL
partial	NULL
dominant	NULL
negative	NULL
effect	NULL
on	NULL
TES2/CTAR2	NULL
mediated	NULL
NF-kB	NULL
activation	NULL
.	NULL

Since	NULL
the	NULL
C-terminal	NULL
residues	NULL
of	NULL
the	NULL
TRADD	NULL
are	NULL
not	NULL
required	NULL
for	NULL
LMP1	NULL
to	NULL
synergize	NULL
with	NULL
TRADD	NULL
in	NULL
NF-	NULL
«	NULL
kB	NULL
activation	NULL
,	NULL
this	NULL
TRADD	NULL
mutant	NULL
likely	NULL
binds	NULL
to	NULL
TES2/CTAR2	NULL
and	NULL
fails	NULL
to	NULL
signal	NULL
because	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
both	NULL
a	NULL
wild-type	NULL
death	NULL
domain	NULL
and	NULL
a	NULL
wild-type	NULL
TRAF	NULL
recruitment	NULL
domain	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
TRADD	NULL
residues	NULL
296	NULL
to	NULL
299	NULL
5766	NULL
IZUMI	NULL
ET	NULL
AL	NULL
.	NULL

or	NULL
300	NULL
to	NULL
302	NULL
for	NULL
TNFR1	NULL
interaction	NULL
and	NULL
for	NULL
downstream	NULL
effects	NULL
and	NULL
their	NULL
lack	NULL
of	NULL
importance	NULL
for	NULL
TES2/CTAR2	NULL
signaling	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
the	NULL
smaller	NULL
TES2/CTAR2	NULL
domain	NULL
interacts	NULL
with	NULL
part	NULL
of	NULL
the	NULL
TRADD	NULL
death	NULL
domain	NULL
and	NULL
thereby	NULL
propagates	NULL
only	NULL
a	NULL
subset	NULL
of	NULL
the	NULL
TNFR1	NULL
inducible	NULL
TRADD	NULL
effects	NULL
.	NULL

While	NULL
TNFR1	NULL
signaling	NULL
through	NULL
TRADD	NULL
results	NULL
in	NULL
death	NULL
domain-mediated	NULL
recruitment	NULL
of	NULL
FADD	NULL
and	NULL
FADD	NULL
-initiated	NULL
apoptosis	NULL
,	NULL
LMP1	NULL
TES2/CTAR2	NULL
signaling	NULL
through	NULL
TRADD	NULL
is	NULL
deficient	NULL
in	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Preliminary	NULL
results	NULL
from	NULL
yeast	NULL
two-hybrid	NULL
analyses	NULL
reveal	NULL
a	NULL
low-level	NULL
LMP1	NULL
TES2/	NULL
CTAR2	NULL
association	NULL
with	NULL
FADD	NULL
.	NULL

Further	NULL
,	NULL
F-LMP1	NULL
immu-noprecipitation	NULL
from	NULL
LCLs	NULL
results	NULL
in	NULL
little	NULL
or	NULL
no	NULL
specific	NULL
coprecipitation	NULL
of	NULL
FADD	NULL
(	NULL
27	NULL
)	NULL
.	NULL

TNFR1-induced	NULL
apoptosis	NULL
is	NULL
accentuated	NULL
by	NULL
blocking	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
with	NULL
cyclo-heximide	NULL
,	NULL
by	NULL
expression	NULL
of	NULL
a	NULL
nondegradable	NULL
IxBa	NULL
«	NULL
,	NULL
or	NULL
by	NULL
other	NULL
interventions	NULL
that	NULL
inhibit	NULL
NF-kB	NULL
or	NULL
JNK/SAPK	NULL
pathways	NULL
(	NULL
3	NULL
,	NULL
48	NULL
,	NULL
55	NULL
,	NULL
57	NULL
)	NULL
.	NULL

Neither	NULL
cycloheximide	NULL
treatment	NULL
nor	NULL
inhibition	NULL
of	NULL
by	NULL
expression	NULL
of	NULL
a	NULL
nondegradable	NULL
IxBa	NULL
enabled	NULL
LMP1	NULL
TES2/CTAR2	NULL
to	NULL
cause	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
either	NULL
LMP1	NULL
TES2/	NULL
CTAR2	NULL
is	NULL
intrinsically	NULL
unable	NULL
to	NULL
transmit	NULL
a	NULL
proapoptotic	NULL
signal	NULL
through	NULL
TRADD	NULL
or	NULL
TES2/CTAR2	NULL
activates	NULL
an	NULL
antiapoptotic	NULL
pathway	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
NF-kB	NULL
or	NULL
new	NULL
protein	NULL
synthe-sis	NULL
.	NULL

LMP1	NULL
thus	NULL
appears	NULL
able	NULL
to	NULL
specifically	NULL
signal	NULL
through	NULL
TRADD	NULL
and	NULL
separate	NULL
NF-xB	NULL
and	NULL
JNK/SAPK	NULL
activation	NULL
from	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Separation	NULL
of	NULL
TRADD-mediated	NULL
effects	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
for	NULL
a	NULL
TRADD	NULL
mutant	NULL
that	NULL
induces	NULL
apoptosis	NULL
but	NULL
not	NULL
NF-kB	NULL
activation	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Another	NULL
difference	NULL
between	NULL
LMP1	NULL
TES2/CTAR2	NULL
and	NULL
TNFR1	NULL
is	NULL
the	NULL
ability	NULL
of	NULL
TES2/CTAR2	NULL
to	NULL
directly	NULL
interact	NULL
with	NULL
another	NULL
death	NULL
domain	NULL
containing	NULL
protein	NULL
the	NULL
Fas	NULL
receptor-interacting	NULL
protein	NULL
RIP	NULL
(	NULL
17	NULL
,	NULL
51	NULL
,	NULL
54	NULL
)	NULL
.	NULL

RIP	NULL
interaction	NULL
was	NULL
diminished	NULL
by	NULL
the	NULL
Y	NULL
;	NULL
5	NULL
,	NULL
TES2/CTAR2	NULL
mutation	NULL
that	NULL
substantially	NULL
diminishes	NULL
TRADD	NULL
interaction	NULL
,	NULL
NF-kB	NULL
activation	NULL
,	NULL
and	NULL
LCL	NULL
outgrowth	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Although	NULL
TES2/CTAR2	NULL
associates	NULL
with	NULL
RIP	NULL
at	NULL
a	NULL
lower	NULL
level	NULL
than	NULL
TRADD	NULL
and	NULL
does	NULL
not	NULL
synergize	NULL
with	NULL
RIP	NULL
in	NULL
NF-kB	NULL
activation	NULL
,	NULL
the	NULL
RIP	NULL
interaction	NULL
is	NULL
substantial	NULL
and	NULL
formally	NULL
opens	NULL
the	NULL
possibility	NULL
that	NULL
RIP	NULL
or	NULL
another	NULL
death	NULL
domain	NULL
protein	NULL
is	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
TRADD	NULL
,	NULL
important	NULL
in	NULL
signaling	NULL
from	NULL
TES2/CTAR2	NULL
.	NULL

RIP	NULL
is	NULL
critical	NULL
for	NULL
TNFR1-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
33	NULL
,	NULL
54	NULL
)	NULL
,	NULL
and	NULL
other	NULL
roles	NULL
are	NULL
likely	NULL
.	NULL

The	NULL
RIP	NULL
kinase	NULL
domain	NULL
has	NULL
no	NULL
known	NULL
function	NULL
,	NULL
and	NULL
RIP-deficient	NULL
mice	NULL
exhibit	NULL
runting	NULL
,	NULL
neonatal	NULL
lethality	NULL
,	NULL
and	NULL
lymphoid	NULL
defects	NULL
that	NULL
are	NULL
not	NULL
fully	NULL
explained	NULL
by	NULL
defects	NULL
in	NULL
TNF-	NULL
«	NULL
signaling	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
sum	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
RIP	NULL
with	NULL
TES2/CTAR2	NULL
,	NULL
the	NULL
association	NULL
of	NULL
RIP	NULL
with	NULL
LMP1	NULL
in	NULL
LCLs	NULL
,	NULL
the	NULL
additive	NULL
effect	NULL
of	NULL
RIP	NULL
with	NULL
LMP1	NULL
TES2/CTAR2	NULL
in	NULL
NF-kB	NULL
activation	NULL
,	NULL
and	NULL
the	NULL
strong	NULL
negative	NULL
effect	NULL
of	NULL
the	NULL
YYD-to-ID	NULL
mutation	NULL
on	NULL
these	NULL
activities	NULL
as	NULL
well	NULL
as	NULL
on	NULL
growth	NULL
transformation	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
RIP	NULL
has	NULL
a	NULL
role	NULL
in	NULL
LMP1	NULL
signaling	NULL
that	NULL
mediates	NULL
growth	NULL
transformation	NULL
.	NULL

A	NULL
quite	NULL
surprising	NULL
aspect	NULL
of	NULL
the	NULL
experiments	NULL
reported	NULL
here	NULL
was	NULL
the	NULL
finding	NULL
that	NULL
LMP1	NULL
differs	NULL
strikingly	NULL
from	NULL
TNFR	NULL
1	NULL
in	NULL
not	NULL
requiring	NULL
RIP	NULL
for	NULL
NF-kB	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
33	NULL
,	NULL
54	NULL
)	NULL
.	NULL

LMP1	NULL
TES2/CTAR2	NULL
activates	NULL
NF-kB	NULL
as	NULL
well	NULL
in	NULL
a	NULL
RIP-deficient	NULL
Jurkat	NULL
cell	NULL
line	NULL
as	NULL
in	NULL
a	NULL
wild-type	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
simplest	NULL
model	NULL
to	NULL
explain	NULL
this	NULL
discrepancy	NULL
is	NULL
that	NULL
RIP	NULL
is	NULL
a	NULL
critical	NULL
part	NULL
of	NULL
the	NULL
TNFR1-TRADD	NULL
signaling	NULL
complex	NULL
that	NULL
activates	NULL
NF-kB	NULL
but	NULL
is	NULL
not	NULL
an	NULL
essential	NULL
mediator	NULL
of	NULL
NF-kB	NULL
activation	NULL
downstream	NULL
of	NULL
TRADD	NULL
.	NULL

In	NULL
RIP-deficient	NULL
cells	NULL
,	NULL
the	NULL
TES2/CTAR2-TRADD	NULL
complex	NULL
activates	NULL
NF-kB	NULL
by	NULL
recruitment	NULL
of	NULL
TRAFs	NULL
to	NULL
the	NULL
TRADD	NULL
N	NULL
terminus	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
dominant	NULL
negative	NULL
effect	NULL
of	NULL
a	NULL
N-terminal	NULL
TRAF2	NULL
deletion	NULL
mutant	NULL
on	NULL
TES2/CTAR2-mediated	NULL
NF-KB	NULL
activation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

These	NULL
and	NULL
previous	NULL
experiments	NULL
indicate	NULL
that	NULL
LMP1	NULL
uses	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

TNFR	NULL
signaling	NULL
molecules	NULL
to	NULL
accomplish	NULL
an	NULL
EBV-specific	NULL
task	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
26	NULL
,	NULL
29	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
LMP1	NULL
amino	NULL
terminus	NULL
and	NULL
six	NULL
transmembrane	NULL
domains	NULL
constitutively	NULL
aggregate	NULL
the	NULL
C-terminal	NULL
cytoplasmic	NULL
domains	NULL
independently	NULL
of	NULL
TNF-	NULL
«	NULL
ligand	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

TES1/CTAR1	NULL
associates	NULL
with	NULL
TRAF1	NULL
,	NULL
-2	NULL
,	NULL
-3	NULL
,	NULL
and	NULL
-5	NULL
,	NULL
activates	NULL
NF-kB	NULL
,	NULL
and	NULL
contributes	NULL
to	NULL
initial	NULL
resting	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
,	NULL
while	NULL
TES2/CTAR2	NULL
associates	NULL
with	NULL
TRADD	NULL
and	NULL
RIP	NULL
,	NULL
activates	NULL
NF-kB	NULL
and	NULL
JNK/SAPK	NULL
,	NULL
and	NULL
enables	NULL
long-term	NULL
lymphoblastoid	NULL
cell	NULL
outgrowth	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
PHS	NULL
grant	NULL
CA47006	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

Danielle	NULL
Rizzo	NULL
provided	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ashkenazi	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1998	NULL
.	NULL

Death	NULL
receptors	NULL
:	NULL
signaling	NULL
and	NULL
mod-ulation	NULL
.	NULL

Science	NULL
281:1305-1308	NULL
.	NULL

2	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Bazan	NULL
,	NULL
D.	NULL
Blanchard	NULL
,	NULL
F.	NULL
Briere	NULL
,	NULL
J.	NULL
P.	NULL
Galizzi	NULL
,	NULL
C.	NULL
van	NULL
Kooten	NULL
,	NULL
Y.	NULL
J.	NULL
Liu	NULL
,	NULL
F.	NULL
Rousset	NULL
,	NULL
and	NULL
S.	NULL
Saeland	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
CD40	NULL
antigen	NULL
and	NULL
its	NULL
ligand	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:881-922	NULL
.	NULL

3	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
essential	NULL
role	NULL
for	NULL
NF-kappaB	NULL
in	NULL
preventing	NULL
TNF-alpha-induced	NULL
cell	NULL
death	NULL
.	NULL

Science	NULL
274:782-784	NULL
.	NULL

4	NULL
.	NULL

Brodeur	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
G.	NULL
Cheng	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
D.	NULL
Thorley-Lawson	NULL
.	NULL

1997	NULL
.	NULL

Localization	NULL
of	NULL
the	NULL
major	NULL
NF-kappaB-activating	NULL
site	NULL
and	NULL
the	NULL
sole	NULL
TRAF3	NULL
binding	NULL
site	NULL
of	NULL
LMP-1	NULL
defines	NULL
two	NULL
distinct	NULL
signaling	NULL
motifs	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:19777-19784	NULL
.	NULL

5	NULL
.	NULL

Cerutti	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Schaffer	NULL
,	NULL
S.	NULL
Shah	NULL
,	NULL
H.	NULL
Zan	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
R.	NULL
G.	NULL
Goodwin	NULL
,	NULL
and	NULL
P.	NULL
Casali	NULL
.	NULL

1998	NULL
.	NULL

CD30	NULL
is	NULL
a	NULL
CD40-inducible	NULL
molecule	NULL
that	NULL
negatively	NULL
regulates	NULL
CD40-mediated	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
in	NULL
non-antigen-selected	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
9:247-256	NULL
.	NULL

6	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
V.	NULL
J.	NULL
Palombella	NULL
,	NULL
F.	NULL
Melandri	NULL
,	NULL
D.	NULL
Scherer	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
site-specific	NULL
phosphorylation	NULL
targets	NULL
I	NULL
kappa	NULL
B	NULL
alpha	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1586-1597	NULL
.	NULL

7	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

TANK	NULL
,	NULL
a	NULL
co-inducer	NULL
with	NULL
TRAF2	NULL
of	NULL
TNF-	NULL
and	NULL
CD	NULL
40L-mediated	NULL
NF-kappaB	NULL
activation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:963-973	NULL
.	NULL

8	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
M.	NULL
Cleary	NULL
,	NULL
Z.	NULL
S.	NULL
Ye	NULL
,	NULL
D.	NULL
I.	NULL
Hong	NULL
,	NULL
S.	NULL
Lederman	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Involvement	NULL
of	NULL
CRAF1	NULL
,	NULL
a	NULL
relative	NULL
of	NULL
TRAF	NULL
,	NULL
in	NULL
CD40	NULL
signaling	NULL
.	NULL

Science	NULL
267:1494-1498	NULL
.	NULL

9	NULL
.	NULL

Devergne	NULL
,	NULL
O.	NULL
,	NULL
E.	NULL
Hatzivassiliou	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
K.	NULL
M.	NULL
Kaye	NULL
,	NULL
M.	NULL
F.	NULL
Kleijnen	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
G.	NULL
Mosialos	NULL
.	NULL

1996	NULL
.	NULL

Association	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
with	NULL
an	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
domain	NULL
important	NULL
for	NULL
B-lymphocyte	NULL
trans-formation	NULL
:	NULL
role	NULL
in	NULL
NF-B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:7098-7108	NULL
.	NULL

10	NULL
.	NULL

Devergne	NULL
,	NULL
O.	NULL
,	NULL
E.	NULL
C.	NULL
McFarland	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
C.	NULL
F.	NULL
Ware	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
TRAF	NULL
binding	NULL
site	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1-induced	NULL
cell	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:7900-7908	NULL
.	NULL

11	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
D.	NULL
M.	NULL
Rothwarf	NULL
,	NULL
E.	NULL
Zandi	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
cytokine-responsive	NULL
IkappaB	NULL
kinase	NULL
that	NULL
activates	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kappaB	NULL
.	NULL

Nature	NULL
388:548-554	NULL
.	NULL

12	NULL
.	NULL

Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1997	NULL
.	NULL

CD30-dependent	NULL
degradation	NULL
of	NULL
TRAF2	NULL
:	NULL
implications	NULL
for	NULL
negative	NULL
regulation	NULL
of	NULL
TRAF	NULL
signaling	NULL
and	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
survival	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:2810-2821	NULL
.	NULL

13	NULL
.	NULL

Durfee	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Becherer	NULL
,	NULL
P.-L.	NULL
Chen	NULL
,	NULL
S.	NULL
Yeh	NULL
,	NULL
Y.	NULL
Yang	NULL
,	NULL
A.	NULL
E.	NULL
Kilburn	NULL
,	NULL
W.	NULL
Lee	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Elledge	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
retinoblastoma	NULL
protein	NULL
associates	NULL
with	NULL
the	NULL
protein	NULL
phosphatase	NULL
type	NULL
1	NULL
catalytic	NULL
subunit	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:555-569	NULL
.	NULL

14	NULL
.	NULL

Eliopoulos	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
L.	NULL
S.	NULL
Young	NULL
.	NULL

1998	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
cJun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
pathway	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
virus-encoded	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
.	NULL

Oncogene	NULL
16:1731-1742	NULL
.	NULL

15	NULL
.	NULL

Floettmann	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
M.	NULL
Rowe	NULL
.	NULL

1997	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP1	NULL
)	NULL
C-terminus	NULL
activation	NULL
region	NULL
2	NULL
(	NULL
CTAR2	NULL
)	NULL
maps	NULL
to	NULL
the	NULL
far	NULL
C-terminus	NULL
and	NULL
requires	NULL
oligomerisation	NULL
for	NULL
NF-kappaB	NULL
activation	NULL
.	NULL

Oncogene	NULL
15:1851-1858	NULL
.	NULL

16	NULL
.	NULL

Gires	NULL
,	NULL
O.	NULL
,	NULL
S.	NULL
U.	NULL
Zimber	NULL
,	NULL
R.	NULL
Gonnella	NULL
,	NULL
M.	NULL
Ueffing	NULL
,	NULL
G.	NULL
Marschall	NULL
,	NULL
R.	NULL
Zeidler	NULL
,	NULL
D.	NULL
Pich	NULL
,	NULL
and	NULL
W.	NULL
Hammerschmidt	NULL
.	NULL

1997	NULL
.	NULL

Latent	NULL
membrane	NULL
protein	NULL
1	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
mimics	NULL
a	NULL
constitutively	NULL
active	NULL
receptor	NULL
molecule	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:6131-6140	NULL
.	NULL

17	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
B	NULL
.	NULL

Z.	NULL
Stanger	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1996	NULL
.	NULL

RIP	NULL
and	NULL
FADD	NULL
:	NULL
two	NULL
``	NULL
death	NULL
domain	NULL
``	NULL
-containing	NULL
proteins	NULL
can	NULL
induce	NULL
apoptosis	NULL
by	NULL
convergent	NULL
,	NULL
but	NULL
disso-ciable	NULL
,	NULL
pathways	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:10923-10927	NULL
.	NULL

18	NULL
.	NULL

Hammerschmidt	NULL
,	NULL
W.	NULL
,	NULL
B.	NULL
Sugden	NULL
,	NULL
and	NULL
V.	NULL
R.	NULL
Baichwal	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
transforming	NULL
domain	NULL
alone	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
is	NULL
toxic	NULL
to	NULL
cells	NULL
when	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:2469-2475	NULL
.	NULL

19	NULL
.	NULL

Hatzivassiliou	NULL
,	NULL
E.	NULL
,	NULL
W.	NULL
E.	NULL
Miller	NULL
,	NULL
N.	NULL
Raab-Traub	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
G.	NULL
Mosialos	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
fusion	NULL
of	NULL
the	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
transmembrane	NULL
domains	NULL
to	NULL
the	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
similar	NULL
to	NULL
LMP1	NULL
in	NULL
constitutive	NULL
activation	NULL
of	NULL
epidemal	NULL
growth	NULL
factor	NULL
receptor	NULL
expression	NULL
,	NULL
nu	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39.	NULL
clear	NULL
factor-kappaB	NULL
and	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160	NULL
:	NULL
1116-1121	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Huang	NULL
,	NULL
H.	NULL
B.	NULL
Shu	NULL
,	NULL
V.	NULL
Baichwal	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

TNF-dependent	NULL
recruitment	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
RIP	NULL
to	NULL
the	NULL
TNF	NULL
recep-tor-1	NULL
signaling	NULL
complex	NULL
.	NULL

Immunity	NULL
4:387-396	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
B.	NULL
Shu	NULL
,	NULL
M.	NULL
G.	NULL
Pan	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

TRADD-TRAF2	NULL
and	NULL
TRADD-FADD	NULL
interactions	NULL
define	NULL
two	NULL
distinct	NULL
TNF	NULL
receptor	NULL
1	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Cell	NULL
84:299-308	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Xiong	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
TNF	NULL
receptor	NULL
1-associated	NULL
protein	NULL
TRADD	NULL
signals	NULL
cell	NULL
death	NULL
and	NULL
NF-kappa	NULL
B	NULL
activation	NULL
.	NULL

Cell	NULL
81:495-504	NULL
.	NULL

Hu	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
M.	NULL
S.	NULL
Boguski	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
RING	NULL
finger	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD40	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30069-30072	NULL
.	NULL

Huen	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
S.	NULL
A.	NULL
Henderson	NULL
,	NULL
C.	NULL
D.	NULL
Croom	NULL
,	NULL
and	NULL
M.	NULL
Rowe	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP1	NULL
)	NULL
mediates	NULL
activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
and	NULL
cell	NULL
surface	NULL
phenotype	NULL
via	NULL
two	NULL
effector	NULL
regions	NULL
in	NULL
its	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

Oncogene	NULL
10:549-560	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Kaye	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Kieff	NULL
.	NULL

1994	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
recombinant	NULL
molecular	NULL
genetic	NULL
analysis	NULL
of	NULL
the	NULL
LMP1	NULL
amino-terminal	NULL
cytoplasmic	NULL
domain	NULL
reveals	NULL
a	NULL
probable	NULL
structural	NULL
role	NULL
,	NULL
with	NULL
no	NULL
component	NULL
essential	NULL
for	NULL
primary	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:4369-4376	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Kaye	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Kief	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
amino	NULL
acid	NULL
sequence	NULL
that	NULL
engages	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
associated	NULL
factors	NULL
is	NULL
critical	NULL
for	NULL
primary	NULL
B	NULL
lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:1447-1152	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Kieff	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Kieff	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
oncogene	NULL
product	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
engages	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
death	NULL
domain	NULL
protein	NULL
to	NULL
mediate	NULL
B	NULL
lymphocyte	NULL
growth	NULL
transformation	NULL
and	NULL
activate	NULL
NF-kappaB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:12592-12597	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
O.	NULL
Devergne	NULL
,	NULL
J.	NULL
N.	NULL
Harada	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
G.	NULL
Mosialos	NULL
.	NULL

1996	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
associated	NULL
factor	NULL
2	NULL
is	NULL
a	NULL
mediator	NULL
of	NULL
NF-kB	NULL
activation	NULL
by	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
,	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:11085-11090	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9150-9154	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
cytoplasmic	NULL
carboxy	NULL
terminus	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
transformation	NULL
;	NULL
fibroblast	NULL
cocultivation	NULL
complements	NULL
a	NULL
critical	NULL
function	NULL
within	NULL
the	NULL
terminal	NULL
155	NULL
residues	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:675-683	NULL
.	NULL

Kehry	NULL
,	NULL
M.	NULL
R.	NULL
1996	NULL
.	NULL

CD4O0-mediated	NULL
signaling	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Balancing	NULL
cell	NULL
survival	NULL
,	NULL
growth	NULL
,	NULL
and	NULL
death	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:2345-2348	NULL
.	NULL

Kelliher	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
S.	NULL
Grimm	NULL
,	NULL
Y.	NULL
Ishida	NULL
,	NULL
F.	NULL
Kuo	NULL
,	NULL
B	NULL
.	NULL

Z.	NULL
Stanger	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
death	NULL
domain	NULL
kinase	NULL
RIP	NULL
mediates	NULL
the	NULL
TNF-induced	NULL
NF-kappaB	NULL
signal	NULL
.	NULL

Immunity	NULL
8:297-303	NULL
.	NULL

Kieser	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Kilger	NULL
,	NULL
O.	NULL
Gires	NULL
,	NULL
M.	NULL
Ueffing	NULL
,	NULL
W.	NULL
Kolch	NULL
,	NULL
and	NULL
W.	NULL
Hammerschmidt	NULL
.	NULL

1997	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
triggers	NULL
AP-1	NULL
activity	NULL
via	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
cascade	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:6478-6485	NULL
.	NULL

Kilger	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Kieser	NULL
,	NULL
M.	NULL
Baumann	NULL
,	NULL
and	NULL
W.	NULL
Hammerschmidt	NULL
.	NULL

1998	NULL
.	NULL

Epstcin-Barr	NULL
virus-mediated	NULL
B-cell	NULL
proliferation	NULL
is	NULL
dependent	NULL
upon	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
,	NULL
which	NULL
simulates	NULL
an	NULL
activated	NULL
CD40	NULL
receptor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:1700-1709	NULL
.	NULL

Lee	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
S.	NULL
Y.	NULL
Lee	NULL
,	NULL
G.	NULL
Kandala	NULL
,	NULL
M.	NULL
L.	NULL
Liou	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
and	NULL
Y.	NULL
Choi	NULL
.	NULL

1996	NULL
.	NULL

CD30/TNF	NULL
receptor-associated	NULL
factor	NULL
interaction	NULL
:	NULL
NF-kappa	NULL
B	NULL
activation	NULL
and	NULL
binding	NULL
specificity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:9699-9703	NULL
.	NULL

Lu	NULL
,	NULL
J	NULL
.	NULL

J.-Y	NULL
.	NULL

,	NULL
J.-Y	NULL
.	NULL

Chen	NULL
,	NULL
T.-Y	NULL
.	NULL

Hsu	NULL
,	NULL
W.	NULL
C.	NULL
Y.	NULL
Yu	NULL
,	NULL
L.-J	NULL
.	NULL

Su	NULL
,	NULL
and	NULL
C.-S.	NULL
Yang	NULL
.	NULL

1996	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
epithelial	NULL
cells	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

77:1883-1892	NULL
.	NULL

Malinin	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
M.	NULL
P.	NULL
Boldin	NULL
,	NULL
A.	NULL
V.	NULL
Kovalenko	NULL
,	NULL
and	NULL
D.	NULL
Wallach	NULL
.	NULL

1997	NULL
.	NULL

MAP3K-related	NULL
kinase	NULL
involved	NULL
in	NULL
NF-kappaB	NULL
induction	NULL
by	NULL
TNF	NULL
,	NULL
CD95	NULL
and	NULL
IL-1	NULL
.	NULL

Nature	NULL
385:540-544	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Zhu	NULL
,	NULL
B.	NULL
W.	NULL
Murray	NULL
,	NULL
A.	NULL
Shevchenko	NULL
,	NULL
B.	NULL
L.	NULL
Bennett	NULL
,	NULL
J.	NULL
Li	NULL
D.	NULL
B	NULL
.	NULL

Young	NULL
,	NULL
M.	NULL
Barbosa	NULL
,	NULL
M.	NULL
Mann	NULL
,	NULL
A.	NULL
Manning	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1997	NULL
.	NULL

IKK-1	NULL
and	NULL
IKK-2	NULL
:	NULL
cytokine-activated	NULL
IkappaB	NULL
kinases	NULL
essential	NULL
for	NULL
NF-kappaB	NULL
LMP1	NULL
SIGNALS	NULL
TRANSFORMATION	NULL
THROUGH	NULL
TRADD	NULL
AND	NULL
RIP	NULL
40	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

5767	NULL
activation	NULL
.	NULL

Science	NULL
278:860-866	NULL
.	NULL

Miller	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
J.	NULL
L.	NULL
Cheshire	NULL
,	NULL
and	NULL
N.	NULL
Raab-Traub	NULL
.	NULL

1998	NULL
.	NULL

Interaction	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
factor	NULL
signaling	NULL
proteins	NULL
with	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
PXQXT	NULL
motif	NULL
is	NULL
essential	NULL
for	NULL
induction	NULL
of	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:2835-2844.	NULL
.	NULL

Miller	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
T.	NULL
N.	NULL
Raab	NULL
.	NULL

1997	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
LMP1	NULL
induction	NULL
of	NULL
the	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
is	NULL
mediated	NULL
through	NULL
a	NULL
TRAF	NULL
signaling	NULL
pathway	NULL
distinct	NULL
from	NULL
NF-kB	NULL
activation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:586-594	NULL
.	NULL

Mitchell	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1995	NULL
.	NULL

Stimulation	NULL
of	NULL
NF-kB-mediated	NULL
transcription	NULL
by	NULL
mutant	NULL
derivatives	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:2968-2976	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
T.	NULL
VanArsdale	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
80:389-399	NULL
.	NULL

Noelle	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

1996	NULL
.	NULL

CD40	NULL
and	NULL
its	NULL
ligand	NULL
in	NULL
host	NULL
defense	NULL
.	NULL

Immunity	NULL
4:415-419	NULL
.	NULL

Park	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
V.	NULL
J.	NULL
Baichwal	NULL
.	NULL

1996	NULL
.	NULL

Systematic	NULL
mutational	NULL
analysis	NULL
of	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
1-associated	NULL
protein	NULL
TRADD	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:9858-9862	NULL
.	NULL

Regnier	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
H.	NULL
Y	NULL
.	NULL

Song	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
and	NULL
M.	NULL
Rothe	NULL
.	NULL

1997	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
IkappaB	NULL
kinase	NULL
.	NULL

Cell	NULL
90:373-383.	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
V.	NULL
M.	NULL
Dixit	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

TRAF2-medi-	NULL
ated	NULL
activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
by	NULL
TNF	NULL
receptor	NULL
2	NULL
and	NULL
CD40	NULL
.	NULL

Science	NULL
269	NULL
:	NULL
1424-1427	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Reinhard	NULL
,	NULL
P.	NULL
Amiri	NULL
,	NULL
and	NULL
L.	NULL
T.	NULL
Williams	NULL
.	NULL

1998	NULL
.	NULL

Early	NULL
activation	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
and	NULL
p38	NULL
kinase	NULL
regulate	NULL
cell	NULL
survival	NULL
in	NULL
response	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:10232-10239	NULL
.	NULL

Sandberg	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
Hammerschmidt	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1997	NULL
.	NULL

Characterization	NULL
of	NULL
LMP-1	NULL
's	NULL
association	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:4649-4656	NULL
.	NULL

Shu	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
M.	NULL
Takeuchi	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
2	NULL
signal	NULL
transducers	NULL
TRAF2	NULL
and	NULL
c-	NULL
IAP1	NULL
are	NULL
components	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
1	NULL
signaling	NULL
complex	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:13973-13978	NULL
.	NULL

Stanger	NULL
,	NULL
B	NULL
.	NULL

Z.	NULL
,	NULL
P.	NULL
Leder	NULL
,	NULL
T.	NULL
H.	NULL
Lee	NULL
,	NULL
E.	NULL
Kim	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1995	NULL
.	NULL

RIP	NULL
:	NULL
a	NULL
novel	NULL
protein	NULL
containing	NULL
a	NULL
death	NULL
domain	NULL
that	NULL
interacts	NULL
with	NULL
Fas/APO-1	NULL
(	NULL
CD95	NULL
)	NULL
in	NULL
yeast	NULL
and	NULL
causes	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
81:513-523	NULL
.	NULL

Sylla	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
S.	NULL
C.	NULL
Hung	NULL
,	NULL
D.	NULL
M.	NULL
Davidson	NULL
,	NULL
E.	NULL
Hatzivassiliou	NULL
,	NULL
N.	NULL
L.	NULL
Malinin	NULL
,	NULL
D.	NULL
Wallach	NULL
,	NULL
T.	NULL
D.	NULL
Gilmore	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
G.	NULL
Mosialos	NULL
.	NULL

1998	NULL
.	NULL

Epstein-Barr	NULL
virus-transforming	NULL
protein	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
activates	NULL
transcription	NULL
factor	NULL
NF-kappaB	NULL
through	NULL
a	NULL
pathway	NULL
that	NULL
includes	NULL
the	NULL
NF-kappaB-inducing	NULL
kinase	NULL
and	NULL
the	NULL
IkappaB	NULL
kinases	NULL
IKKalpha	NULL
and	NULL
IKKbeta	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:10106-10111	NULL
.	NULL

Tartaglia	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
T.	NULL
M.	NULL
Ayres	NULL
,	NULL
G.	NULL
H.	NULL
Wong	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
novel	NULL
domain	NULL
within	NULL
the	NULL
55	NULL
kd	NULL
TNF	NULL
receptor	NULL
signals	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
74:845-853	NULL
.	NULL

Ting	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
F.	NULL
Pimentel-Muinos	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1996	NULL
.	NULL

RIP	NULL
mediates	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
1	NULL
activation	NULL
of	NULL
NF-kappaB	NULL
but	NULL
not	NULL
Fas/APO-1-initiated	NULL
apoptosis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:6189-6196	NULL
.	NULL

Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
S.	NULL
J.	NULL
Martin	NULL
,	NULL
T.	NULL
Kafri	NULL
,	NULL
D.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
TNF-alpha-induced	NULL
apoptosis	NULL
by	NULL
NF-kappaB	NULL
.	NULL

Science	NULL
274:787-789	NULL
.	NULL

VanArsdale	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
S.	NULL
L.	NULL
VanArsdale	NULL
,	NULL
W.	NULL
R.	NULL
Force	NULL
,	NULL
B.	NULL
N.	NULL
Walter	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
J.	NULL
C.	NULL
Reed	NULL
,	NULL
and	NULL
C.	NULL
F.	NULL
Ware	NULL
.	NULL

1997	NULL
.	NULL

Lymphotoxin-beta	NULL
receptor	NULL
signaling	NULL
complex	NULL
:	NULL
role	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
factor	NULL
3	NULL
recruitment	NULL
in	NULL
cell	NULL
death	NULL
and	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
kappaB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:2460-2465	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
M.	NULL
W.	NULL
Mayo	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Baldwin	NULL
.	NULL

1996	NULL
.	NULL

TNF-	NULL
and	NULL
cancer	NULL
therapy-induced	NULL
apoptosis	NULL
:	NULL
potentiation	NULL
by	NULL
inhibition	NULL
of	NULL
NF-kappaB	NULL
.	NULL

Science	NULL
274:784-787	NULL
.	NULL

Woronicz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1997	NULL
.	NULL

IkappaB	NULL
kinase-beta	NULL
:	NULL
NF-kappaB	NULL
activation	NULL
and	NULL
complex	NULL
formation	NULL
with	NULL
IkappaB	NULL
kinase-alpha	NULL
and	NULL
NIK	NULL
.	NULL

Science	NULL
278:866-869	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
M.	NULL
Rothwarf	NULL
,	NULL
M.	NULL
Delhase	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IkappaB	NULL
kinase	NULL
complex	NULL
(	NULL
IKK	NULL
)	NULL
contains	NULL
two	NULL
kinase	NULL
subunits	NULL
,	NULL
IKKalpha	NULL
and	NULL
IKKbeta	NULL
,	NULL
necessary	NULL
for	NULL
IkappaB	NULL
phosphorylation	NULL
and	NULL
NF-kappaB	NULL
activation	NULL
.	NULL

Cell	NULL
91:243-252	NULL
.	NULL

